<html lang="en-GB" style="" class="js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths no-highres"><head><script async="" src="//static.ads-twitter.com/uwt.js"></script><script type="text/javascript" async="" src="https://snap.licdn.com/li.lms-analytics/insight.min.js"></script><script src="https://connect.facebook.net/signals/config/117159282237256?v=2.8.47&amp;r=stable" async=""></script><script async="" src="//connect.facebook.net/en_US/fbevents.js"></script><script src="https://connect.facebook.net/en_US/sdk.js?hash=2b1faecc768ef985c755672b36e1fed8&amp;ua=modern_es6" async="" crossorigin="anonymous"></script><script async="" src="https://dmcqaqmkk1tj3.cloudfront.net/2.8.2/bij9ahH4.js" crossorigin="anonymous" integrity="sha384-JH3Mlf8Y0LAVR3hG3KUJjKMR5zZggIgm3TOtnarXDO02oGFYPLvqOdC45kDoHQp+"></script><script type="text/javascript" async="" src="//ssl.siteimprove.com/js/siteanalyze_667563.js"></script><script type="text/javascript" async="" src="https://apis.google.com/js/platform.js" gapi_processed="true"></script><script id="twitter-wjs" src="https://platform.twitter.com/widgets.js"></script><script id="facebook-jssdk" src="//connect.facebook.net/en_US/sdk.js#xfbml=1&amp;version=v2.4"></script><script async="" src="//dmcqaqmkk1tj3.cloudfront.net/novonordisk.js"></script><script type="text/javascript" async="" src="https://www.googleadservices.com/pagead/conversion_async.js"></script><script>
        var disClaimerParent="";
        var session= sessionStorage.getItem(disClaimerParent);
        if(session==null){
            if(disClaimerParent!=''){
               window.location.href = 'http://www.coagulationassays.com/.html?disclaim=http://www.novonordisk.com/media/novo-nordisk-news.html/';
            }
        }
    </script>

	<script>

</script>
<!-- adding script tag for Implementation of Tag Manager -->
	<script type="text/javascript" src="//assets.adobedtm.com/32b00585d6817c80ac5c08b80bb1863a4d26024f/satelliteLib-6b7341adfb4a3d0f55b44e0ae458d0cfad3950c9.js"></script><!-- Global site tag (gtag.js) - Google Ads: 990209275 --> <script async="" src="https://www.googletagmanager.com/gtag/js?id=AW-990209275"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'AW-990209275'); </script> 

<base target="_parent">
    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
    <meta name="keywords" content="Novo Nordisk press releases, Novo Nordisk company announcements, news, stock exchange announcements">
    <meta name="description" content="Press releases and company announcements">
    <meta name="robots" content="INDEX, FOLLOW">

    <link rel="canonical" href="http://www.novonordisk.com/media/novo-nordisk-news.html">

    <!--FACEBOOK & LINKEDIN-->
<meta property="og:title" content="">
<meta property="og:locale" content="en_GB">
<meta property="og:type" content="website">
<meta property="og:url" content="http://www.novonordisk.com/media/novo-nordisk-news.html">
<meta property="og:image" content="">
<meta property="og:description" content="Press releases and company announcements">    
<!--TWITTER-->
<meta name="twitter:title" content="">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:url" content="http://www.novonordisk.com/media/novo-nordisk-news.html">
<meta name="twitter:image" content="">
<meta name="twitter:description" content="Press releases and company announcements">
<meta name="twitter:site" content="@novonordisk">
<!--GOOGLE+-->
<meta itemprop="name" content="">
<meta itemprop="url" content="http://www.novonordisk.com/media/novo-nordisk-news.html">
<meta itemprop="image" content="">
<meta itemprop="description" content="Press releases and company announcements">






<meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no">
<script type="text/javascript" src="/etc/designs/nextweb/csslibs/modernizr.min.js"></script>
<!--[if lt IE 10]><link rel="stylesheet" href="/etc/designs/nextweb/csslibs/main-ie.min.css" type="text/css"/>
<![endif]-->
<!--[if gte IE 10]><!--><link rel="stylesheet" href="/etc/designs/nextweb/csslibs/main.min.css" type="text/css">
<!--<![endif]-->
<link rel="stylesheet" href="/etc/designs/nextweb/csslibs/print.css" media="print all">


<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="#">
    <link rel="icon" type="image/vnd.microsoft.icon" href="/etc/designs/nextweb-large-livecopy-designs/Denmark/HQ/www-novonordisk-com/en_gb/favicon.ico">
    <link rel="shortcut icon" type="image/vnd.microsoft.icon" href="/etc/designs/nextweb-large-livecopy-designs/Denmark/HQ/www-novonordisk-com/en_gb/favicon.ico">
    <title>News archive</title><script>
            var appInsights=window.appInsights||function(a){
                function b(a){c[a]=function(){var b=arguments;c.queue.push(function(){c[a].apply(c,b)})}}var c={config:a},d=document,e=window;setTimeout(function(){var b=d.createElement("script");b.src=a.url||"https://az416426.vo.msecnd.net/scripts/a/ai.0.js",d.getElementsByTagName("script")[0].parentNode.appendChild(b)});try{c.cookie=d.cookie}catch(a){}c.queue=[];for(var f=["Event","Exception","Metric","PageView","Trace","Dependency"];f.length;)b("track"+f.pop());if(b("setAuthenticatedUserContext"),b("clearAuthenticatedUserContext"),b("startTrackEvent"),b("stopTrackEvent"),b("startTrackPage"),b("stopTrackPage"),b("flush"),!a.disableExceptionTracking){f="onerror",b("_"+f);var g=e[f];e[f]=function(a,b,d,e,h){var i=g&&g(a,b,d,e,h);return!0!==i&&c["_"+f](a,b,d,e,h),i}}return c
            }({
                instrumentationKey:"a6d301bc-cc09-4ca0-bd4c-f88ab0fa050a"
            });

            window.appInsights=appInsights,appInsights.queue&&0===appInsights.queue.length&&appInsights.trackPageView();
        </script>
    <script src="https://az416426.vo.msecnd.net/scripts/a/ai.0.js"></script><script src="https://googleads.g.doubleclick.net/pagead/viewthroughconversion/990209275/?random=1555566749957&amp;cv=9&amp;fst=1555566749957&amp;num=1&amp;bg=ffffff&amp;guid=ON&amp;resp=GooglemKTybQhCsO&amp;eid=376635471&amp;u_h=768&amp;u_w=1366&amp;u_ah=728&amp;u_aw=1366&amp;u_cd=24&amp;u_his=1&amp;u_tz=-300&amp;u_java=false&amp;u_nplug=3&amp;u_nmime=4&amp;gtm=2oa430&amp;sendb=1&amp;data=event%3Dgtag.config&amp;frm=0&amp;url=https%3A%2F%2Fwww.novonordisk.com%2Fcontent%2FDenmark%2FHQ%2Fwww-novonordisk-com%2Fen_gb%2Fhome%2Fmedia%2Fnovo-nordisk-news.html%2F&amp;ref=https%3A%2F%2Fwww.google.com%2F&amp;tiba=News%20archive&amp;async=1&amp;rfmt=3&amp;fmt=4"></script><script src="https://assets.adobedtm.com/32b00585d6817c80ac5c08b80bb1863a4d26024f/scripts/satellite-59e4808c64746d4af70005b2.js"></script><script src="https://assets.adobedtm.com/32b00585d6817c80ac5c08b80bb1863a4d26024f/scripts/satellite-5a3ba84964746d0f920000fb.js"></script><script src="https://assets.adobedtm.com/32b00585d6817c80ac5c08b80bb1863a4d26024f/scripts/satellite-5aaa4a3d64746d531c0046d9.js"></script><style type="text/css">.fb_hidden{position:absolute;top:-10000px;z-index:10001}.fb_reposition{overflow:hidden;position:relative}.fb_invisible{display:none}.fb_reset{background:none;border:0;border-spacing:0;color:#000;cursor:auto;direction:ltr;font-family:"lucida grande", tahoma, verdana, arial, sans-serif;font-size:11px;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:1;margin:0;overflow:visible;padding:0;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;visibility:visible;white-space:normal;word-spacing:normal}.fb_reset>div{overflow:hidden}@keyframes fb_transform{from{opacity:0;transform:scale(.95)}to{opacity:1;transform:scale(1)}}.fb_animate{animation:fb_transform .3s forwards}
.fb_dialog{background:rgba(82, 82, 82, .7);position:absolute;top:-10000px;z-index:10001}.fb_dialog_advanced{border-radius:8px;padding:10px}.fb_dialog_content{background:#fff;color:#373737}.fb_dialog_close_icon{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 0 transparent;cursor:pointer;display:block;height:15px;position:absolute;right:18px;top:17px;width:15px}.fb_dialog_mobile .fb_dialog_close_icon{left:5px;right:auto;top:5px}.fb_dialog_padding{background-color:transparent;position:absolute;width:1px;z-index:-1}.fb_dialog_close_icon:hover{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 -15px transparent}.fb_dialog_close_icon:active{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 -30px transparent}.fb_dialog_iframe{line-height:0}.fb_dialog_content .dialog_title{background:#6d84b4;border:1px solid #365899;color:#fff;font-size:14px;font-weight:bold;margin:0}.fb_dialog_content .dialog_title>span{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yd/r/Cou7n-nqK52.gif) no-repeat 5px 50%;float:left;padding:5px 0 7px 26px}body.fb_hidden{height:100%;left:0;margin:0;overflow:visible;position:absolute;top:-10000px;transform:none;width:100%}.fb_dialog.fb_dialog_mobile.loading{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/ya/r/3rhSv5V8j3o.gif) white no-repeat 50% 50%;min-height:100%;min-width:100%;overflow:hidden;position:absolute;top:0;z-index:10001}.fb_dialog.fb_dialog_mobile.loading.centered{background:none;height:auto;min-height:initial;min-width:initial;width:auto}.fb_dialog.fb_dialog_mobile.loading.centered #fb_dialog_loader_spinner{width:100%}.fb_dialog.fb_dialog_mobile.loading.centered .fb_dialog_content{background:none}.loading.centered #fb_dialog_loader_close{clear:both;color:#fff;display:block;font-size:18px;padding-top:20px}#fb-root #fb_dialog_ipad_overlay{background:rgba(0, 0, 0, .4);bottom:0;left:0;min-height:100%;position:absolute;right:0;top:0;width:100%;z-index:10000}#fb-root #fb_dialog_ipad_overlay.hidden{display:none}.fb_dialog.fb_dialog_mobile.loading iframe{visibility:hidden}.fb_dialog_mobile .fb_dialog_iframe{position:sticky;top:0}.fb_dialog_content .dialog_header{background:linear-gradient(from(#738aba), to(#2c4987));border-bottom:1px solid;border-color:#1d3c78;box-shadow:white 0 1px 1px -1px inset;color:#fff;font:bold 14px Helvetica, sans-serif;text-overflow:ellipsis;text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0;vertical-align:middle;white-space:nowrap}.fb_dialog_content .dialog_header table{height:43px;width:100%}.fb_dialog_content .dialog_header td.header_left{font-size:12px;padding-left:5px;vertical-align:middle;width:60px}.fb_dialog_content .dialog_header td.header_right{font-size:12px;padding-right:5px;vertical-align:middle;width:60px}.fb_dialog_content .touchable_button{background:linear-gradient(from(#4267B2), to(#2a4887));background-clip:padding-box;border:1px solid #29487d;border-radius:3px;display:inline-block;line-height:18px;margin-top:3px;max-width:85px;padding:4px 12px;position:relative}.fb_dialog_content .dialog_header .touchable_button input{background:none;border:none;color:#fff;font:bold 12px Helvetica, sans-serif;margin:2px -12px;padding:2px 6px 3px 6px;text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0}.fb_dialog_content .dialog_header .header_center{color:#fff;font-size:16px;font-weight:bold;line-height:18px;text-align:center;vertical-align:middle}.fb_dialog_content .dialog_content{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/y9/r/jKEcVPZFk-2.gif) no-repeat 50% 50%;border:1px solid #4a4a4a;border-bottom:0;border-top:0;height:150px}.fb_dialog_content .dialog_footer{background:#f5f6f7;border:1px solid #4a4a4a;border-top-color:#ccc;height:40px}#fb_dialog_loader_close{float:left}.fb_dialog.fb_dialog_mobile .fb_dialog_close_button{text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0}.fb_dialog.fb_dialog_mobile .fb_dialog_close_icon{visibility:hidden}#fb_dialog_loader_spinner{animation:rotateSpinner 1.2s linear infinite;background-color:transparent;background-image:url(https://static.xx.fbcdn.net/rsrc.php/v3/yD/r/t-wz8gw1xG1.png);background-position:50% 50%;background-repeat:no-repeat;height:24px;width:24px}@keyframes rotateSpinner{0%{transform:rotate(0deg)}100%{transform:rotate(360deg)}}
.fb_iframe_widget{display:inline-block;position:relative}.fb_iframe_widget span{display:inline-block;position:relative;text-align:justify}.fb_iframe_widget iframe{position:absolute}.fb_iframe_widget_fluid_desktop,.fb_iframe_widget_fluid_desktop span,.fb_iframe_widget_fluid_desktop iframe{max-width:100%}.fb_iframe_widget_fluid_desktop iframe{min-width:220px;position:relative}.fb_iframe_widget_lift{z-index:1}.fb_iframe_widget_fluid{display:inline}.fb_iframe_widget_fluid span{width:100%}</style><style type="text/css" media="all" id="sz_cib_styling">.szc_info>div{display:none}body.szc_displaying{bottom:0;height:auto;left:0;overflow:hidden;position:fixed;right:0;top:0}.szc_info{background-color:transparent;bottom:0;color:#000;font-size:12px;left:0;position:absolute;right:0;top:0;z-index:65665}body>.szc_info{bottom:auto;height:1px;left:-1px;position:fixed;right:auto;top:-1px;width:1px}.szc_info.szc_dark{color:#FFF}.szc_info *{box-sizing:content-box;-moz-box-sizing:content-box;-webkit-box-sizing:content-box;font-size:12px;line-height:normal;margin:0;padding:0}.szc_info>div{display:block;font-family:Arial,Verdana,Geneva,sans-serif;font-size:12px;font-weight:normal;line-height:1.5em;text-align:left}.szc_info table{background-color:transparent;border:0;bottom:auto;display:table;float:none;left:auto;position:relative;right:auto;top:auto}.szc_info table thead{background-color:transparent;border:0;bottom:auto;display:table-header-group;float:none;left:auto;position:relative;right:auto;top:auto}.szc_info table thead tr{background-color:transparent;border:0;bottom:auto;display:table-row;float:none;left:auto;position:relative;right:auto;top:auto}.szc_info table thead tr th{background-color:transparent;border:0;bottom:auto;display:table-cell;float:none;left:auto;position:relative;right:auto;top:auto}.szc_info table tbody{background-color:transparent;border:0;bottom:auto;display:table-row-group;float:none;left:auto;position:relative;right:auto;top:auto}.szc_info table tbody tr{background-color:transparent;border:0;bottom:auto;display:table-row;float:none;left:auto;position:relative;right:auto;top:auto}.szc_info table tbody tr td{background-color:transparent;border:0;bottom:auto;display:table-cell;float:none;left:auto;position:relative;right:auto;top:auto}.szc_info .szc_overlay{background-color:#000;display:none;filter:alpha(opacity=55);height:100%;left:0;opacity:.55;position:fixed;top:0;width:100%;z-index:3}.szc_info.szc_dark .szc_overlay{background-color:#fff}.szc_info .szc_smallbox,.szc_info .szc_widebox{bottom:0;color:#555;display:none;height:auto;left:0;min-height:50px;position:absolute;z-index:2}.szc_info .szc_smallbox:hover,.szc_info .szc_widebox:hover{background-color:#fff;background-color:rgba(255,255,255,0.75);text-decoration:none}.szc_info .szc_smallbox:hover{cursor:pointer}body>.szc_info .szc_smallbox,body>.szc_info .szc_widebox{position:fixed}.szc_info.szc_dark .szc_smallbox,.szc_info.szc_dark .szc_widebox{background-color:#000;background-color:rgba(0,0,0,0.55);color:#bbb}.szc_info.szc_dark .szc_smallbox:hover{background-color:#000;background-color:rgba(0,0,0,0.75)}.szc_info .szc_smallbox{background-color:#fff;background-color:rgba(255,255,255,0.55);height:50px;width:auto}.szc_info .szc_widebox{background-color:#fff;background-color:rgba(255,255,255,0.75);min-width:320px;width:560px}.szc_info.szc_dark .szc_widebox{background-color:#000;background-color:rgba(0,0,0,0.75)}.szc_info .szc_smallbox table,.szc_info .szc_widebox table{height:100%;min-height:50px;width:100%}.szc_info .szc_smallbox table tbody tr td,.szc_info .szc_widebox table tbody tr td{color:#555;padding:8px 8px 8px 0;vertical-align:middle}.szc_info.szc_dark .szc_smallbox table tbody tr td,.szc_info.szc_dark .szc_widebox table tbody tr td{color:#bbb}.szc_info .szc_smallbox table tbody tr td.szc_first,.szc_info .szc_widebox table tbody tr td.szc_first{white-space:nowrap;padding-left:8px}.szc_info .szc_widebox table tbody tr td.szc_second{white-space:normal;width:100%}.szc_info .szc_widebox table tbody tr td.szc_second a{color:#555}.szc_info .szc_widebox table tbody tr td.szc_third{white-space:nowrap}.szc_info .szc_widebox table tbody tr td.szc_third a.szc_first{margin-right:8px}.szc_info.szc_dark .szc_widebox table tbody tr td.szc_second a{color:#bbb}.szc_info.szc_round .szc_smallbox,.szc_info.szc_round .szc_widebox{border-radius:0 6px 0 0;-khtml-border-radius:0 6px 0 0;-moz-border-radius:0 6px 0 0;-webkit-border-radius:0 6px 0 0}.szc_info.szc_pos_rb .szc_smallbox,.szc_info.szc_pos_rb .szc_widebox{left:auto;right:0}.szc_info.szc_pos_rb.szc_round .szc_smallbox,.szc_info.szc_pos_rb.szc_round .szc_widebox{border-radius:6px 0 0 0;-khtml-border-radius:6px 0 0 0;-moz-border-radius:6px 0 0 0;-webkit-border-radius:6px 0 0 0}.szc_info.szc_pos_rt .szc_smallbox,.szc_info.szc_pos_rt .szc_widebox{bottom:auto;left:auto;right:0;top:0}.szc_info.szc_pos_rt.szc_round .szc_smallbox,.szc_info.szc_pos_rt.szc_round .szc_widebox{border-radius:0 0 0 6px;-khtml-border-radius:0 0 0 6px;-moz-border-radius:0 0 0 6px;-webkit-border-radius:0 0 0 6px}.szc_info.szc_pos_lt .szc_smallbox,.szc_info.szc_pos_lt .szc_widebox{bottom:auto;top:0}.szc_info.szc_pos_lt.szc_round .szc_smallbox,.szc_info.szc_pos_lt.szc_round .szc_widebox{border-radius:0 0 6px 0;-khtml-border-radius:0 0 6px 0;-moz-border-radius:0 0 6px 0;-webkit-border-radius:0 0 6px 0}.szc_info .szc_bigbox{background-color:#FFF;display:none;height:450px;left:50%;margin-left:-450px;margin-top:-225px;min-height:200px;min-width:320px;position:fixed;top:50%;width:900px;z-index:3}.szc_info.szc_dark .szc_bigbox{background-color:#222}.szc_info.szc_round .szc_bigbox{border-radius:10px;-khtml-border-radius:10px;-moz-border-radius:10px;-webkit-border-radius:10px}.szc_info .szc_bigbox h1{font-weight:normal!important;font-size:2em!important;margin:.67em 0}.szc_info .szc_bigbox h2{font-weight:normal!important;font-size:1.5em!important;margin:.75em 0}.szc_info .szc_bigbox h3{font-weight:bold!important;font-size:1.17em!important;margin:.83em 0 .40em 0}.szc_info .szc_bigbox h4{font-weight:bold!important}.szc_info .szc_bigbox h5{font-weight:bold!important;font-size:.83em!important}.szc_info .szc_bigbox h6{font-weight:bold!important;font-size:.75em!important}.szc_info .szc_bigbox .szc_bigbox_head{height:78px;left:0;margin:15px 15px 0 15px;position:absolute;right:0;top:0}.szc_info .szc_bigbox .szc_bigbox_head h2{line-height:63px;color:#000;margin:0}.szc_info.szc_dark .szc_bigbox .szc_bigbox_head h2{color:#FFF}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs{float:right}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a{color:#FFF;cursor:pointer;display:block;float:left;font-size:11px;font-family:arial!important;height:52px;margin:0 0 0 2px;overflow:hidden;padding:12px 2px;text-align:center;text-decoration:none;width:74px;z-index:2400}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_first{margin-left:0}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected{background:#f5f5f5;border-style:solid;border-color:#E2E2E2;border-width:1px 1px 0 1px;color:#555;padding:11px 2px 15px 2px;position:relative;width:72px}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_unavailable{cursor:not-allowed}.szc_info.szc_dark .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected{background:#555;border-color:#555;color:#FFF}.szc_info.szc_round .szc_bigbox .szc_bigbox_head .szc_tabs a{border-radius:6px;-khtml-border-radius:6px;-moz-border-radius:6px;-webkit-border-radius:6px}.szc_info.szc_round .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected{border-radius:6px 6px 0 0;-khtml-border-radius:6px 6px 0 0;-moz-border-radius:6px 6px 0 0;-webkit-border-radius:6px 6px 0 0}.szc_info .szc_bigbox .szc_bigbox_main{background:#f5f5f5;border:1px solid #E2E2E2;bottom:65px;color:#555;font-weight:normal;left:0;margin:0 15px;overflow:auto;position:absolute;right:0;top:93px;-webkit-overflow-scrolling:touch}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main{background:#555;border:1px solid #555;color:#FFF}.szc_info .szc_bigbox .szc_bigbox_main *{color:#555}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main *{color:#FFF}.szc_info .szc_bigbox .szc_bigbox_main.szc_no_scroll{overflow:hidden}.szc_bigbox_main [data-info-section]{display:none}.szc_info .szc_bigbox .szc_bigbox_main a{color:#555;text-decoration:underline}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main a{color:#FFF;text-decoration:underline}.szc_info .szc_bigbox .szc_bigbox_main p{margin-bottom:8px;display:block}.szc_info .szc_bigbox .szc_bigbox_main p+h1{margin-top:36px}.szc_info .szc_bigbox .szc_bigbox_main p+h2{margin-top:28px}.szc_info .szc_bigbox .szc_bigbox_main p+h3{margin-top:16px;font-weight:bold!important}.szc_info .szc_bigbox .szc_bigbox_main p a{text-decoration:underline}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=information]{padding:15px}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=information] ul{list-style:disc outside none;margin-bottom:8px}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=information] ul li{margin-left:30px}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=explain]{padding:10px;min-height:30px}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=explain] .szc_accept_box{background:#DBDBDB;color:#555;float:right;margin:0 0 7px 7px;padding:8px 8px 7px 8px}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main div[data-info-section=explain] .szc_accept_box{background-color:transparent;border:1px solid #888;color:#FFF}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=explain] .szc_accept_box span{cursor:pointer}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=explain] .szc_accept_box span a{border:1px solid #555;background:#FFF;padding:1px 1px 0 1px;text-decoration:none}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=explain] .szc_accept_box span a i{margin-top:1px;visibility:hidden}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=explain] .szc_accept_box.szc_selected span a i{visibility:visible}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=declineoverlay]{background:#f5f5f5;bottom:0;filter:alpha(opacity=90);left:0;opacity:.90;position:absolute;right:0;z-index:1}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main div[data-info-section=declineoverlay]{background:#555}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=declineoverlay] table{height:100%;margin:0;padding:0;width:100%}.szc_info .szc_bigbox .szc_bigbox_main div[data-info-section=declineoverlay] table td{font-style:italic;text-align:center;vertical-align:middle}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table{border:0;border-spacing:0;*border-collapse:collapse;margin:0;width:100%;-webkit-overflow-scrolling:touch}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tr{z-index:0}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>thead>tr>th,.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td{border-right:1px solid #000;border-right-color:rgba(0,0,0,0.1);line-height:13px;padding:8px 10px;text-align:left;vertical-align:middle;width:20%}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>thead>tr>th.szc_fourth,.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_fourth{border-right:none!important}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>thead>tr>th{background:#555;color:#fff;font-size:10px;font-weight:normal}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr.szc_data_table_row_odd>td{background:#ddd}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr.szc_data_table_row_even>td{background:#f5f5f5}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td{white-space:nowrap}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_no_data{border-right:0;text-align:center}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_first table{border:0;margin:0;padding:0;width:100%}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_first table td{padding:0}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_first table tr.szc_first td{width:50%;white-space:nowrap}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_first table tr.szc_first td.szc_second{padding-left:2px;text-align:right}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td a[data-si-type=help]{text-decoration:none}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td span{display:none}.szc_info .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td span.szc_number_label{background:#444;border-radius:9px;-khtml-border-radius:9px;-moz-border-radius:9px;-webkit-border-radius:9px;color:#fff;cursor:pointer;display:inline-block;font-size:10px;font-weight:bold;line-height:11px;margin-top:-2px;min-width:12px;padding:4px 4px;text-align:center;vertical-align:middle;width:auto}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>thead>tr>th{background:#bbb;color:#222}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>thead>tr>th,.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td{border-right:1px solid #fff;border-right-color:rgba(255,255,255,0.1)}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_no_data{border-right:0}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr.szc_data_table_row_odd>td{background:#444}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr.szc_data_table_row_even>td{background:#555}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td span.szc_number_label{background:#CCC;color:#444}.szc_info .szc_bigbox .szc_bigbox_foot{bottom:0;color:#888;height:40px;left:0;margin:0 15px 15px 15px;position:absolute;right:0}.szc_info .szc_bigbox .szc_bigbox_foot a{color:#888;text-decoration:underline}.szc_info .szc_bigbox .szc_bigbox_foot table{border:0;border-spacing:0;height:100%;margin:0;padding:0;width:100%}.szc_info .szc_bigbox .szc_bigbox_foot table tr{background:transparent;border:0;float:none;width:100%}.szc_info .szc_bigbox .szc_bigbox_foot table tr td{background:transparent;border:0;color:#888;float:none;display:table-cell;margin:0;padding:0;position:relative;vertical-align:middle;white-space:nowrap}.szc_info .szc_bigbox .szc_bigbox_foot table tr td.szc_first{font-family:arial!important}.szc_info .szc_bigbox .szc_bigbox_foot table tr td.szc_second{text-align:right}.szc_info .szc_bigbox .szc_bigbox_foot table td td.szc_second a{white-space:nowrap}.szc_info [class*="szc_button"]{color:#FFF!important;cursor:pointer;display:inline-block;font-family:arial!important;height:16px;padding:12px 12px;text-decoration:none!important;white-space:nowrap}.szc_info .szc_button_neutral{background:#ccc!important;color:#000!important}.szc_info.szc_round .szc_button{border-radius:6px;-khtml-border-radius:6px;-moz-border-radius:6px;-webkit-border-radius:6px}.szc_info .szc_bigbox .szc_bigbox_main .szc_hoverbox{border:1px solid #000;border-top:0;border-left:none;box-shadow:0 1px 4px 0 #000;box-shadow:0 1px 4px 0 rgba(0,0,0,0.4);-moz-box-shadow:0 1px 4px 0 #000;-moz-box-shadow:0 1px 4px 0 rgba(0,0,0,0.4);-o-box-shadow:0 1px 4px 0 #000;-o-box-shadow:0 1px 4px 0 rgba(0,0,0,0.4);-webkit-box-shadow:0 1px 4px 0 #000;-webkit-box-shadow:0 1px 4px 0 rgba(0,0,0,0.4);color:#222;display:none;left:0;position:fixed;text-align:left;top:0;width:250px;z-index:4000}.szc_info.szc_round .szc_bigbox .szc_bigbox_main .szc_hoverbox{border-radius:6px;-khtml-border-radius:6px;-moz-border-radius:6px;-webkit-border-radius:6px}.szc_info .szc_bigbox .szc_bigbox_main .szc_hoverbox.szc_displaying{z-index:5000}.szc_info .szc_bigbox .szc_bigbox_main .szc_hoverbox>div{background:#222;color:#fff;padding:10px;white-space:normal}.szc_info .szc_bigbox .szc_bigbox_main .szc_hoverbox>div.szc_second{background:#444}.szc_info.szc_round .szc_bigbox .szc_bigbox_main .szc_hoverbox>div.szc_first{border-radius:6px 6px 0 0;-khtml-border-radius:6px 6px 0 0;-moz-border-radius:6px 6px 0 0;-webkit-border-radius:6px 6px 0 0}.szc_info.szc_round .szc_bigbox .szc_bigbox_main .szc_hoverbox>div.szc_second{border-radius:0 0 6px 6px;-khtml-border-radius:0 0 6px 6px;-moz-border-radius:0 0 6px 6px;-webkit-border-radius:0 0 6px 6px}.szc_info .szc_bigbox .szc_bigbox_main .szc_hoverbox>div.szc_second{background:#444}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_hoverbox>div{background:#ddd;color:#000}.szc_info.szc_dark .szc_bigbox .szc_bigbox_main .szc_hoverbox>div.szc_second{background:#eee}.szc_info [class*="szc_icon_"]{background-image:url('//cookieinfo.siteimprove.com/img/cookie-sprite.png');background-repeat:no-repeat;display:block;margin:auto;vertical-align:text-top}.szc_info .szc_icon_close{background-position:-160px -0px;display:inline-block;height:13px;margin-top:1px;width:13px}.szc_info .szc_button_neutral .szc_icon_close{background-position:-160px -40px}.szc_info .szc_icon_info_small{background-position:-200px -40px;height:18px;margin:5px 0;width:18px}.szc_info.szc_dark .szc_icon_info_small{background-position:-200px 0}.szc_info .szc_icon_info_small.szc_icon_purpose{cursor:pointer;display:inline-block;margin-bottom:0;margin-left:5px;margin-top:-1px}.szc_info .szc_icon_dynamic{background-position:-240px -40px;cursor:pointer;display:inline-block;height:14px;margin-left:5px;width:17px}.szc_info.szc_dark .szc_icon_dynamic{background-position:-240px 0}.szc_info .szc_icon_info{background-position:-1px -1px;height:28px;margin-bottom:6px;width:28px}.szc_info .szc_icon_statistics{background-position:-120px -0px;height:30px;margin-bottom:4px;width:30px}.szc_info .szc_icon_marketing{background-position:-80px -0px;height:29px;margin-bottom:5px;width:31px}.szc_info .szc_icon_functional{background-position:-40px -0px;height:30px;margin-bottom:4px;width:30px}.szc_info .szc_icon_questionmark{background-position:-280px -40px;display:inline-block;height:18px;margin-top:-2px;width:18px}.szc_info.szc_dark .szc_icon_questionmark{background-position:-280px -0px}.szc_info .szc_icon_checkmark{background-position:-320px -40px;display:inline-block;height:12px;width:14px}.szc_info .szc_button .szc_icon_checkmark{background-position:-320px -0px}.szc_info .szc_loading [class*="szc_icon_"]{background:url('//cookieinfo.siteimprove.com/img/load.gif') no-repeat;background-position:6px 11px;display:block;height:28px;width:28px}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected .szc_icon_info{background-position:0 -40px}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected .szc_icon_statistics{background-position:-120px -40px}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected .szc_icon_marketing{background-position:-80px -40px}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected .szc_icon_functional{background-position:-40px -40px}.szc_info.szc_dark .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected .szc_icon_info{background-position:-1px -1px}.szc_info.szc_dark .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected .szc_icon_statistics{background-position:-120px 0}.szc_info.szc_dark .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected .szc_icon_marketing{background-position:-80px 0}.szc_info.szc_dark .szc_bigbox .szc_bigbox_head .szc_tabs a.szc_selected .szc_icon_functional{background-position:-40px 0}.szc_info * {font-family: arial !important}.szc_info .szc_bigbox .szc_bigbox_head .szc_tabs a, .szc_info .szc_bigbox .szc_bigbox_foot a.szc_button, .szc_info .szc_widebox td.szc_third .szc_button {background-color: #656565}</style><style type="text/css" media="(max-width: 900px)" id="sz_cib_styling_mq_1">.szc_info .szc_bigbox{left:0;right:0;margin-left:0;width:auto}</style><style type="text/css" media="(max-height: 450px)" id="sz_cib_styling_mq_2">.szc_info .szc_bigbox{bottom:0;height:auto;margin-top:0;min-height:320px;top:0}</style><style type="text/css" media="(max-width: 560px)" id="sz_cib_styling_mq_3">.szc_info.szc_round .szc_bigbox{border-radius:0;-khtml-border-radius:0;-moz-border-radius:0;-webkit-border-radius:0}.szc_info .szc_widebox{left:0;max-width:560px;right:0;width:auto}.szc_info .szc_bigbox{min-width:320px}.szc_info .szc_bigbox .szc_bigbox_head{margin:2px 0 0 0}.szc_info .szc_bigbox .szc_bigbox_head h2{line-height:50px;margin:.75em .75em .75em 16px}.szc_info .szc_bigbox .szc_bigbox_main{bottom:44px;margin:0;overflow-x:auto;top:80px}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main{overflow-x:hidden}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>thead>tr{display:none}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr{display:block}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td{border-right:none!important;box-sizing:border-box;-moz-box-sizing:border-box;-webkit-box-sizing:border-box;display:block;left:0;float:left;position:relative;right:0;width:100%}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_first{border-top:1px solid #000;border-top-color:rgba(0,0,0,0.05)}.szc_info.szc_switch_table.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_first{border-top:1px solid #fff;border-top-color:rgba(255,255,255,0.05)}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td>span{display:inline-block;width:120px}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr>td.szc_first>div.szc_first{left:130px;position:absolute;right:10px;top:8px}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr.szc_data_table_row_even>td{background:#ddd}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr.szc_data_table_row_odd>td{background:#f5f5f5}.szc_info.szc_switch_table.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr.szc_data_table_row_even>td{background:#444}.szc_info.szc_switch_table.szc_dark .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr.szc_data_table_row_odd>td{background:#555}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr .szc_hoverbox{color:inherit;position:relative;left:auto;top:auto;bottom:auto;right:auto;margin-top:5px;border:0;box-shadow:none;-moz-box-shadow:none;-o-box-shadow:none;-webkit-box-shadow:none;width:auto;margin-left:120px}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr .szc_hoverbox>div{background:transparent;border:0;color:inherit;padding:0}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr .szc_hoverbox>div.szc_first{font-weight:bold;text-decoration:underline}.szc_info.szc_switch_table .szc_bigbox .szc_bigbox_main .szc_data_table>tbody>tr .szc_hoverbox.szc_displaying{display:block}.szc_info .szc_bigbox .szc_bigbox_foot{margin:0 0 2px 0;padding:0 2px}.szc_info .szc_bigbox .szc_bigbox_foot table tr td a.szc_button.szc_first{margin-right:2px}.szc_info .szc_bigbox .szc_bigbox_foot table tr td.szc_first{white-space:normal}</style><style type="text/css" media="(max-width: 425px)" id="sz_cib_styling_mq_4">.szc_info .szc_bigbox .szc_bigbox_head h2{display:none}</style></head>
<body class="false" lang="en"><div class="szc_info szc_switch_table szc_dark szc_pos_lb"><div class="szc_overlay"></div><div class="szc_bigbox"><div class="szc_bigbox_head"><div class="szc_tabs" role="tablist"><a href="#information" tabindex="3" title="Information" role="button" data-tab-section="information" class="szc_first"><i class="szc_icon_info"></i>Information</a><a href="#functional" tabindex="3" title="Functionality" role="button" data-tab-section="functional" class="szc_loading szc_unavailable"><i class="szc_icon_functional"></i>Functionality</a><a href="#statistics" tabindex="3" title="Statistics" role="button" data-tab-section="statistics" class="szc_loading szc_unavailable"><i class="szc_icon_statistics"></i>Statistics</a><a href="#marketing" tabindex="3" title="Marketing" role="button" data-tab-section="marketing" class="szc_loading szc_unavailable"><i class="szc_icon_marketing"></i>Marketing</a></div><h2>Cookies</h2></div><div class="szc_bigbox_main"><div data-info-section="title"><h1></h1></div><div data-info-section="information"><p><strong>Information about cookies</strong></p>
<p>A cookie is a small text file, which is placed on your computer or other device. It makes it possible for us to recognise your computer and gather information about which pages and functions are visited with your computer. Cookies contain only anonymous information.</p>
<p>Cookies are used by most websites and are in many cases essential for the website to work properly.</p>
<p><strong>Cookies on this website</strong></p>
<p>We use cookies on this website for various purposes related to functionality, web analysis and marketing. However, most cookies we use to gather statistics about your visit. This information we can use to improve the user experience on our website.</p>
<p>You can read more about the cookies we use under the three tabs. The cookies are divided into categories and you will find information about name, expiration, purpose and company.</p>
<p><strong>How to disable cookies in your browser</strong></p>
<p>If you want to block the use of cookies you must change the permissions in your browser setting.</p>
<p>If you block cookies in your browser, your device will not be tracked when you visit our website. However, please note that by declining cookies some website functionalities may not work correctly.</p>
<p><strong>Why do we inform about cookies?</strong></p>
<p>We inform about cookies because we want to be transparent in the way we communicate with our stakeholders. EU has also made a privacy directive which you can read more about here: <a href="https://eur-lex.europa.eu/eli/reg/2016/679/oj" tabindex="4"><span>General Data Protection Regulation (EU) 2016/679 ("GDPR")</span></a></p></div><div data-info-section="explain"><div class="szc_first"></div></div></div><div class="szc_bigbox_foot"><table><tbody><tr><td class="szc_first">Powered by <a href="http://siteimprove.com/" target="_blank" tabindex="5">Siteimprove</a></td><td class="szc_second"><a class="szc_button szc_first" tabindex="6" href="#close" title="Close" role="button" data-button-action="close"><i class="szc_icon_close"></i> Close</a></td></tr></tbody></table></div></div><div class="szc_widebox" style="display: none; width: 0px; height: 50px; min-width: 0px;"><table style="display: none;"><tbody><tr><td class="szc_first"><i class="szc_icon_info_small"></i></td><td class="szc_second">You accept the use of cookies by continuing to browse the site or closing this banner.</td><td class="szc_third"><!--<a class="szc_button szc_button_small szc_button_neutral szc_first" href="#open" title="About Cookies" role="button" tabindex="1">About Cookies</a><a class="szc_button szc_button_small szc_second" href="#accept" title="{BUTTON-ACCEPT}" role="button" tabindex="1" data-button-action="accept">{BUTTON-ACCEPT}</a><a class="szc_button szc_button_small szc_second" href="#decline" title="{BUTTON-DECLINE}" role="button" tabindex="1" data-button-action="decline">{BUTTON-DECLINE}</a><a class="szc_button szc_button_small szc_second" href="#close" title="Close" role="button" tabindex="1" data-button-action="close"><i class="szc_icon szc_icon_close"></i> Close</a>--><a class="szc_button szc_button_neutral szc_first" href="#open" title="About Cookies" role="button" tabindex="1" data-button-action="about">About Cookies</a><a class="szc_button szc_second" href="#close" title="Close" role="button" tabindex="1" data-button-action="close"><i class="szc_icon szc_icon_close"></i> Close</a></td></tr></tbody></table></div><a class="szc_smallbox" href="#open" title="Cookies" style="width: 86px; display: inline;"><table style="display: table;"><tbody><tr><td class="szc_first"><i class="szc_icon_info_small"></i></td><td class="szc_second">Cookies</td></tr></tbody></table></a></div>
    <div class="clientcontext parbase"><script type="text/javascript" src="/etc.clientlibs/clientlibs/granite/jquery.min.js"></script>
<script type="text/javascript" src="/etc.clientlibs/clientlibs/granite/utils.min.js"></script>
<script type="text/javascript" src="/etc.clientlibs/clientlibs/granite/jquery/granite.min.js"></script>
<script type="text/javascript" src="/etc.clientlibs/foundation/clientlibs/jquery.min.js"></script>
<script type="text/javascript" src="/etc.clientlibs/foundation/clientlibs/shared.min.js"></script>
<script type="text/javascript" src="/etc.clientlibs/clientlibs/granite/lodash/modern.min.js"></script>
<script type="text/javascript" src="/etc.clientlibs/cq/personalization/clientlib/personalization/kernel.min.js"></script>
<script type="text/javascript">
    $CQ(function() {
        CQ_Analytics.SegmentMgr.loadSegments("/etc/segmentation");
        CQ_Analytics.ClientContextUtils.init("/etc/clientcontext/default","/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/novo-nordisk-news");

        
    });
</script>
</div>
<script type="text/javascript" src="/etc/designs/nextweb/headlibs/vendor.min.js"></script>
<div class="header_par headertoolbar"><div id="exit-ramp" data-message=""></div>
<div id="exit-ramp-hosts" data-whitelist=""></div>


<header role="header" class="header">
      <!-- START c58-ie8-disclaimer-top component-->
		<!--[if lte IE 8]>
		      <div id="ie8-disclaimer-top" class="ie8-disclaimer-top">
		        <div class="ie8-disclaimer-body">
		          <p>Please use Google Chrome when browsing novonordisk.com or any other
  external website in Novo Nordisk. </p>
 <p>
  <a adhocenable="false"
    href="http://globeshare.novonordisk.com/GNM2/pages/ShowNewsItem.aspx?GNM2NewsItemId=12705"
    target="_blank">You can read more about Google Chrome for work here</a></p>
<a id="" href="#" title="" rel="" role="" target="" class="ie8-close-disclaimer-body"><img src="/etc/designs/nextweb/csslibs/images/icons/modal-close-dlpx.png" alt="" title="" role="presentation" class="img img-responsive js-image-responsive"/></a>
		        </div>
		      </div>
		<![endif]-->

<!-- END c57-ie8-disclaimer component-->
<div class="container">

	<div class="row">
	<div class="logo"><div class="col-xs-3 col-sm-1"><a href="/" rel="" role="" target="">
            <img class="img img-responsive js-image-responsive header-logo " title="" alt="Novo Nordisk logo" role="presentation" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/novo-logo-dhpx.image.136.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/novo-logo-dhpx.image.136.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/novo-logo-dhpx.image.68.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/novo-logo-dhpx.image.68.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/novo-logo-dhpx.image.136.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/novo-logo-dhpx.image.68.0.png" src="/content/dam/Denmark/HQ/Commons/images/novo-logo-dhpx.image.68.0.png"></a>
       </div>
   </div>
<div class="visible-xs hamburger"> </div>
        </div>




	<div class="header-navigation">
        <div class="searchbox"><form id="site-search-form" name="site-search-form" action="/search.html" method="get" class="site-search-form">
    <fieldset>
        <input type="text" name="query" class="site-search-input">
        <input type="hidden" name="pno" value="1">
        <label for="">
        </label>
        <button type="button" tabindex="" class="site-search-button"><i class="fa fa-rotate-90 fa-search"></i>
        </button>
    </fieldset>
</form></div>
<div class="visible-xs mobile-top-bar row">
        	<a href="#" rel="" role="" target="" class="mobile-close-nav-button">
           		<i class="fa fa-times"></i>
            </a>
        	<a href="/media/novo-nordisk-news.html/.html" rel="" role="" target="" class="mobile-nav-home-button">
               <i class="fa fa-home"></i>
            </a>
		</div>

			<div class="mega-navigation meganavigation"><div class="main-nav row">
		<nav>
		 <!-- In case of Mobile devices -->
            <div class="mobile-main-back"><a href="#" rel="" role="" target="">Back</a></div>
            <ul class="main-nav-links" role="">
                <li role="" class="">
                         <a target="" role="" rel="" href="/patients.html" class="expandable">Patients</a>
                           <div class="megamenu">
                                <div class="row">
                                    <a class="secondary-link visible-xs" target="" role="" rel="" href="/patients.html">Patients</a>
                                    <div class="col-sm-3 megamenu-col" data-equalize-id="Patients">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/patients/diabetes-care.html">Diabetes</a>
                                                    <ul role="">
                                                    <li role="" class="tertiary-link visible-xs">
														<a href="/patients/diabetes-care.html" rel="" role="" target="">Diabetes</a>
													</li> 
                                                        <li role=""><a target="" role="" rel="" href="/patients/diabetes-care/type-1.html">Type 1</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/patients/diabetes-care/type-2.html">Type 2</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/patients/diabetes-care/Gestational-diabetes.html">Gestational diabetes</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/patients/diabetes-care/pens--needles-and-injection-support.html">Pens, needles and injection support</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-3 megamenu-col" data-equalize-id="Patients">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/patients/obesity.html">Obesity</a>
                                                    <ul role="">
                                                    <li role="" class="tertiary-link visible-xs">
														<a href="/patients/obesity.html" rel="" role="" target="">Obesity</a>
													</li> 
                                                        <li role=""><a target="" role="" rel="" href="/patients/obesity/understanding-obesity.html">Understanding obesity</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/patients/obesity/treating-obesity.html">Treating obesity</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/patients/obesity/living-with-obesity.html">Living with obesity</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-3 megamenu-col" data-equalize-id="Patients">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/patients/haemostasis-management.html">Haemophilia</a>
                                                    <ul role="">
                                                        </ul>
                                                <a class="secondary-link expandable" target="" role="" rel="" href="/patients/growth-disorders.html">Growth disorders</a>
                                                    <ul role="">
                                                        </ul>
                                                <a class="secondary-link expandable" target="" role="" rel="" href="/patients/hormone-replacement-therapy-overview.html">Hormone replacement therapy</a>
                                                    <ul role="">
                                                        </ul>
                                                </div>
                                    <div class="col-sm-3 megamenu-col" data-equalize-id="Patients">
                                            <a class="secondary-link first-level" target="" role="" rel="" href="/patients/DEEP.html">Disease experience expert panel (DEEP)</a>                                             
                                                    <p class="hidden-xs">A partnership that benefits patients</p>                                              
                                                <a class="secondary-link first-level" target="_blank" role="" rel="" href="https://www.novonordisk-trials.com/">Clinical trials</a>                                             
                                                    <p class="hidden-xs">What is a clinical trial and how to participate.</p>                                              
                                                </div>
                                    </div>
                            </div>
                           </li>
                        <li role="" class="">
                         <a target="" role="" rel="" href="/research-and-development.html" class="expandable">Research &amp; Development</a>
                           <div class="megamenu">
                                <div class="row">
                                    <a class="secondary-link visible-xs" target="" role="" rel="" href="/research-and-development.html">Research &amp; Development</a>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Research &amp; Development">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/research-and-development/science-and-innovation.html">Science &amp; innovation</a>
                                                    <ul role="">
                                                    <li role="" class="tertiary-link visible-xs">
														<a href="/research-and-development/science-and-innovation.html" rel="" role="" target="">Science &amp; innovation</a>
													</li> 
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/science-and-innovation/scientific-approach.html">Our scientific approach</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/science-and-innovation/stem-cell-research.html">Stem cell research</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/science-and-innovation/r-d-facts-and-figures.html">R&amp;D facts &amp; figures</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/science-and-innovation/global-r-and-d-centres.html">Global R&amp;D centres</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/science-and-innovation/publications.html">Publications</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Research &amp; Development">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/research-and-development/our-therapy-areas.html">Our therapy areas</a>
                                                    <ul role="">
                                                    <li role="" class="tertiary-link visible-xs">
														<a href="/research-and-development/our-therapy-areas.html" rel="" role="" target="">Our therapy areas</a>
													</li> 
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/our-therapy-areas/type-1-diabetes.html">Type 1 diabetes</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/our-therapy-areas/type-2-diabetes.html">Type 2 diabetes</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/our-therapy-areas/obesity.html">Obesity</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/our-therapy-areas/atherosclerosis.html">Atherosclerosis</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/our-therapy-areas/nash.html">NASH</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/our-therapy-areas/haemophilia.html">Haemophilia</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/our-therapy-areas/growth-disorders.html">Growth disorders</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Research &amp; Development">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/research-and-development/partner-with-us.html">Partner with us</a>
                                                    <ul role="">
                                                    <li role="" class="tertiary-link visible-xs">
														<a href="/research-and-development/partner-with-us.html" rel="" role="" target="">Partner with us</a>
													</li> 
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/partner-with-us/partnering-opportunities.html">Partnering opportunities</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/partner-with-us/events-and-meetings.html">Events &amp; meetings</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/partner-with-us/contact-us.html">Contact us</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Research &amp; Development">
                                            <a class="secondary-link first-level" target="" role="" rel="" href="/research-and-development/future-science.html">Future science</a>                                             
                                                    <p class="hidden-xs">Look at our future science</p>                                              
                                                <a class="secondary-link first-level" target="" role="" rel="" href="/research-and-development/pipeline.html">Pipeline</a>                                             
                                                    <p class="hidden-xs">Review our clinical pipeline</p>                                              
                                                <a class="secondary-link first-level" target="_blank" role="" rel="" href="https://www.novonordisk-trials.com/">Clinical trials</a>                                             
                                                    <p class="hidden-xs">What is a clinical trial and how to participate</p>                                              
                                                </div>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Research &amp; Development">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/research-and-development/bioethics.html">Bioethics</a>
                                                    <ul role="">
                                                    <li role="" class="tertiary-link visible-xs">
														<a href="/research-and-development/bioethics.html" rel="" role="" target="">Bioethics</a>
													</li> 
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/bioethics/animal-ethics.html">Animal ethics</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/bioethics/clinical-trial-ethics.html">Clinical trial ethics</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/bioethics/human-biosample-ethics.html">Human biosample ethics</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/bioethics/stem-cell-ethics.html">Stem cell ethics</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/research-and-development/bioethics/gene-technology-ethics.html">Gene technology ethics</a></li>
                                                        </ul>
                                                </div>
                                    </div>
                            </div>
                           </li>
                        <li role="" class="">
                         <a target="" role="" rel="" href="/sustainable-business.html" class="expandable">Sustainable business</a>
                           <div class="megamenu">
                                <div class="row">
                                    <a class="secondary-link visible-xs" target="" role="" rel="" href="/sustainable-business.html">Sustainable business</a>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Sustainable business">
                                            <a class="secondary-link first-level" target="" role="" rel="" href="/sustainable-business.html">A sustainable company</a>                                             
                                                    <p class="hidden-xs">We believe that a healthy environment, society and economy are fundamental to long-term business success, and we will play our part, also on the long-term.</p>                                              
                                                </div>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Sustainable business">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/sustainable-business/commitment-to-access-and-affordability.html">Access and affordability in diabetes</a>
                                                    <ul role="">
                                                    <li role="" class="tertiary-link visible-xs">
														<a href="/sustainable-business/commitment-to-access-and-affordability.html" rel="" role="" target="">Access and affordability in diabetes</a>
													</li> 
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/commitment-to-access-and-affordability/our-access-to-insulin-commitment.html">Our access commitment</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/commitment-to-access-and-affordability/medicines-affordability-in-the-us.html">Medicines affordability in the US</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/commitment-to-access-and-affordability/programmes-and-partnerships.html">Programmes and partnerships</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/commitment-to-access-and-affordability/world-diabetes-foundation.html">World Diabetes Foundation</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Sustainable business">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/sustainable-business/zero-environmental-impact.html">Zero environmental impact</a>
                                                    <ul role="">
                                                    <li role="" class="tertiary-link visible-xs">
														<a href="/sustainable-business/zero-environmental-impact.html" rel="" role="" target="">Zero environmental impact</a>
													</li> 
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/zero-environmental-impact/circular-company.html">Reducing our company footprint</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/zero-environmental-impact/circular-product.html">Designing products for reuse &amp; recycling</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/zero-environmental-impact/circular-supply.html">Environmentally responsible supply chain</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Sustainable business">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/sustainable-business/performance-on-tbl.html">Transparency &amp; reporting</a>
                                                    <ul role="">
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/performance-on-tbl/responsible-business-practices/human-rights.html">Human rights</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/performance-on-tbl/more-about-how-we-work-and-report/integrated-reporting.html">Integrated reporting</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/performance-on-tbl/more-about-how-we-work-and-report/the-sustainable-development-goals.html">The Sustainable Development Goals</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/sustainable-business/performance-on-tbl/more-about-how-we-work-and-report/principles-positions-and-policies.html">Principles, positions and policies</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-2 megamenu-col" data-equalize-id="Sustainable business">
                                            <a class="secondary-link first-level" target="" role="" rel="" href="/sustainable-business/faq.html">Frequently asked questions</a>                                             
                                                    <p class="hidden-xs">Find answers to some of the more frequently asked questions on sustainability and responsible business practices.</p>                                              
                                                </div>
                                    </div>
                            </div>
                           </li>
                        <li role="" class="">
                         <a target="" role="" rel="" href="/careers.html" class="expandable">Careers</a>
                           <div class="megamenu">
                                <div class="row">
                                    <a class="secondary-link visible-xs" target="" role="" rel="" href="/careers.html">Careers</a>
                                    <div class="col-sm-3 megamenu-col" data-equalize-id="Careers">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/careers.html">Join us</a>
                                                    <ul role="">
                                                        <li role=""><a target="" role="" rel="" href="/careers/working-at-novo-nordisk/available-jobs.html">Available Jobs</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/working-at-novo-nordisk/email-job-agent.html">Email Job Agent</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/working-at-novo-nordisk.html">Working at Novo Nordisk</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/working-at-novo-nordisk/employee-perspectives.html">Employee Perspectives</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/working-at-novo-nordisk/moving-to-denmark.html">Moving to Denmark</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/working-at-novo-nordisk/moving-to-denmark/meet-us-event-calendar.html">Meet Us - Event Calendar</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-3 megamenu-col" data-equalize-id="Careers">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/careers/professionals.html">Professionals</a>
                                                    <ul role="">
                                                        <li role=""><a target="" role="" rel="" href="/careers/professionals/research-and-development.html">Research &amp; Development</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/professionals/manufacturing.html">Manufacturing</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/professionals/corporate-functions.html">Corporate Functions</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/professionals/finance-legal-ir.html">Finance, Investor Relations, and Procurement</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/professionals/it.html">IT</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-3 megamenu-col" data-equalize-id="Careers">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/careers/career-programmes.html">Career programmes</a>
                                                    <ul role="">
                                                        <li role=""><a target="" role="" rel="" href="/careers/career-programmes/fellowships-scholarships.html">PhD and PostDocs</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/career-programmes/mds.html">Pharmaceutical Medicine Programme (PMP)</a></li>
                                                        </ul>
                                                </div>
                                    <div class="col-sm-3 megamenu-col" data-equalize-id="Careers">
                                            <a class="secondary-link expandable" target="" role="" rel="" href="/careers/graduates-students-and-trainees.html">Graduates, students and trainees</a>
                                                    <ul role="">
                                                        <li role=""><a target="" role="" rel="" href="/careers/graduates-students-and-trainees/graduates.html">Graduates</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/graduates-students-and-trainees/students.html">Students</a></li>
                                                        <li role=""><a target="" role="" rel="" href="/careers/graduates-students-and-trainees/trainees.html">Trainees - Elev</a></li>
                                                        </ul>
                                                </div>
                                    </div>
                            </div>
                           </li>
                        <li role="" class="">
                         <a target="" role="" rel="" href="/about-novo-nordisk.html">About Novo Nordisk</a>
                           </li>
                        </ul>
        </nav> 
</div>
</div>
<div class="utility-nav row">
			<span class="">
        			<div class="drclicklogout parbase"><form action="/bin/drclicklogout" method="POST" name="drclicklogout" id="drclicklogout">
<input type="hidden" id="logonpage" name="logonpage" value="null">

</form>  


<script type="text/javascript">
    function deleteAllCookies() {
        var cookies = document.cookie.split(";");

        for (var i = 0; i < cookies.length; i++) {
            var cookie = cookies[i];
            var eqPos = cookie.indexOf("=");
            var name = eqPos > -1 ? cookie.substr(0, eqPos) : cookie;
            console.log(name);
            document.cookie = name + "=;expires=Thu, 01 Jan 1970 00:00:00 GMT";
        }
    }


	$("#drclicklogoutbutton").click(function (){   
        deleteAllCookies();
          $("#drclicklogout").submit();
	});
</script>


<!-- START-style-->
<style type="text/css">
    		#drclicklogoutbutton {
        	font-size: 13px;
        	font-family: verdana;
		    position: relative;
		    padding: 0 0 0 15px;
		    margin-top:4px;
		}
		    .header .header-navigation .drclicklogout {
		        display: inline-block;
		    }
		    @media screen and (min-width: 768px) {
		        #drclicklogoutbutton {
		        display: inline-block;
            	font-family: verdana;
            	font-size: 11px;

		        }
                form#drclicklogout{
            		margin-top:-19px;
                }
		    }

</style></div>
</span>
                 <span class="utility-nav-divider"></span>

       		 <ul role="" class="utility-links hcp-utility-container">
	        	


					<li role="">
	                		<a class="current" href="/media.html" rel="" role="" target="">Media</a>
	                    </li>
                         <li role="">
	                		<a class="" href="/products.html" rel="" role="" target="">Products</a>
	                    </li>
                         <li role="">
	                		<a class="" href="/investors.html" rel="" role="" target="">Investors</a>
	                    </li>
                         <li role="">
	                		<a class="" href="/research-and-development/partner-with-us.html" rel="" role="" target="">Partnering</a>
	                    </li>
                         <li role="">
	                		<a class="" href="/contact-us.html" rel="" role="" target="">Contact us</a>
	                    </li>
                         <li role="" class="hcp-utility-links">
	        	</li></ul>
	         </div>
		<div class="map-link">
	     		<a href="/about-novo-nordisk/worldmap.html" rel="" role="" target="">
	     		<div class="map-text"><span>Novo Nordisk Worldwide</span></div>
			<img class="img img-responsive js-image-responsive" title="" alt="" role="presentation" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.152.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.268.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.76.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.134.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.268.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.134.0.png" src="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.134.0.png"></a>
	      	</div>
	    </div>
</div>
</header>
<div class="header-overlay hidden-xs hide"></div>


<script type="text/javascript">
              $(document).ready(function () {
                var strHcpUtilityLinks = $('.header .header-navigation .utility-nav ul li.hcp-utility-links').wrap("</p>").parent().html();
                //console.log(strHcpUtilityLinks);
                $('.header .header-navigation .utility-nav ul li.hcp-utility-links').unwrap();
                if(true == $('.header .header-navigation .utility-nav li').hasClass('hcp-utility-links')) {
                  $('.header .header-navigation .utility-nav ul').addClass('hcp-utility-container');
                  console.log('true')
                  $('.header .header-navigation .utility-nav li:first-child').remove();
                  $('.header .header-navigation .utility-nav ul').append(strHcpUtilityLinks);
                }
              });
</script>

<style type="text/css">
        .header .header-navigation .utility-nav .hcp-utility-container li:first-child a { margin-left: 20px;  }
        .hcp-utility-container .hcp-utility-links { float: right;  }
        .hcp-utility-container .hcp-utility-links a { margin-right: 14px; line-height: 18px;  }
        .hcp-utility-container .hcp-utility-links a:last-child { margin-right: 0;  }
        @media (max-width: 768px), print {
          .header .header-navigation .utility-nav .hcp-utility-container li:first-child a { margin-left: 0;  }
          .hcp-utility-container .hcp-utility-links { float: inherit;  }
        }
</style>
</div>
<div class="content-wrapper">
	<div class="leftnav_mobile leftNavigationMobile"><!-- START c32-mobile-left-nav component-->
<div class="mobile-left-nav">
    <a href="/media.html" rel="" role="" target="" class="mobile-left-nav-back">
   		 <span>Back</span>
     	</a>
    	<a href="/media/novo-nordisk-news.html" rel="" role="" target="" class="mobile-left-nav-current"><span class="mobile-left-nav-icon"></span>News archive</a>
            </div>
<!-- END c32-mobile-left-nav component-->

</div>
<div class="par_fullwidth parsys">
</div>
<div class="container">
    	<div class="row">
        	<div class="col-xs-12 col-sm-12">
	            <!-- START c6-breadcrumbs component-->
	            <div class="breadcrumbplaceholder"><ul class="breadcrumbs-header">
                <div class="nnbreadcrumbs breadcrumbs"><li role="">
              <a class="" target="" role="" rel="" href="/">Home</a></li>
       <li role="">
              <span> /</span><a class="" target="" role="" rel="" href="/media.html">Media</a></li>
       <li role="">
              <span> /</span><a class="current" target="" role="" rel="" href="/media/novo-nordisk-news.html">News archive</a></li>
       </div>
</ul>
        <div class="article-share-tools breadcrumb-tools share-button-floatright">
                <div class="socialshare_iparsys iparsys parsys"><div class="section"><div class="new"></div>
</div><div class="iparys_inherited"><div class="socialshare_iparsys iparsys parsys"><div class="socialsharebutton section"><!-- START c19-article-share-tools component-->
		<!-- END c19-article-share-tools component-->
    </div>
</div>
</div>
</div>
</div>
        </div>
<!-- END c6-breadcrumbs component-->
        	</div>
    	</div>
    </div>

	<div class="container">
    <div class="row">
        <div class="col-xs-12 col-sm-12">
            <div class="par_fullcolumn parsys">
</div>
</div>
    </div>
    <div class="row">
        <div class="col-xs-12 col-sm-2 left-rail">          
           <div class="leftnav_2Col leftNavigationDesktop"><!-- START c7-desktop-left-nav component-->
<ul class="desktop-left-nav" role="">
        <li role="">
            <a href="/media.html" rel="" role="" target="" class="false">Media</a>
            <ul role="" class=" ">
                    <li role="">
                        <a href="/media/novo-nordisk-news.html" rel="" role="" target="" class="current">News archive</a>
                        </li>
                            <li role="">
                        <a href="/media/facts-about-intro.html" rel="" role="" target="" class="false">Novo Nordisk facts</a>
                        </li>
                            <li role="">
                        <a href="/media/rd-pipeline.html" rel="" role="" target="" class="false">R&amp;D pipeline</a>
                        </li>
                            <li role="">
                        <a href="/media/Perspectives.html" rel="" role="" target="" class="false">Perspectives</a>
                        </li>
                            <li role="">
                        <a href="/media/broadcast-room.html" rel="" role="" target="" class="false">Broadcast room</a>
                        </li>
                            <li role="">
                        <a href="/media/photo-library-02.html" rel="" role="" target="" class="false">Photos</a>
                        </li>
                            <li role="">
                        <a href="/media/products.html" rel="" role="" target="" class="false">Products</a>
                        </li>
                            <li role="">
                        <a href="/media/subscribe.html" rel="" role="" target="" class="false">Subscribe</a>
                        </li>
                            <li role="">
                        <a href="/media/contact-media.html" rel="" role="" target="" class="false">Contact</a>
                        </li>
                            </ul>
            </li>
    </ul>
</div>
</div>
        <div class="col-xs-12 col-sm-10 content-col">
            <div class="par_right parsys"><div class="multicolumn section"><div class="row ">
            <div class="col-xs-12 col-sm-4">
                <div class="par-c0 parsys"><div class="novotitle section"><div class="block-title">
            <h1 id="">News archive</h1>
        </div>
    </div>

</div>
</div>
            <div class="col-xs-12 col-sm-8">
                <div class="par-c1 parsys"><div class="customstyles section"><div class="row">
        <div class="" style="hidden-xs" id="">
            <div class="customstyles_par parsys"><div class="novotext text parbase section">
    
    <p style="text-align: right;">
  <a adhocenable="false" href="http://www.novonordisk.com/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/subscribe.html">Subscribe
    to company announcements and press releases</a></p>

    
    
</div>

</div>
</div>
    </div>
</div>

</div>
</div>
        </div>
    </div>
<div class="novotext text parbase section">
    
    <h3>Press releases are intended for the media.&nbsp;</h3>
 <p>Product-related press releases will only be available&nbsp;<a href="mailto:amhg@novonordisk.com">upon request</a>&nbsp;after three
  weeks of publication on our website in order to comply with applicable regulation.</p>

    
    
</div>
<div class="newssearch parbase section"><script type="text/javascript">

$(document).ready(function(){
    //showYears();
    //var cyear = new Date().getFullYear();
    //$('.customSelectInner').html(cyear);
});

$(document).ready(function () {
    $('#searchtext').keypress(function(e) {
        if(e.which == 13) {
            return false;
        }
    });
});

 function getParameterByName(name) {
    name = name.replace(/[\[]/, "\\[").replace(/[\]]/, "\\]");
    var regex = new RegExp("[\\?&]" + name + "=([^&#]*)"),
        results = regex.exec(location.search);
    return results == null ? "" : decodeURIComponent(results[1].replace(/\+/g, " "));
}

function SubmitSearchForm () {
		var searchValue = document.getElementById('searchtext').value;
        var yearValue = document.getElementById('year').value;

    	if (yearValue == "0") {
            return false;
        }
        else {
            //alert("Submit form on year change !!");
            document.forms['media-archive-search-box-form'].submit();
            return true;                                            
        }
        return false;        
    }
function showYears() {
    var queryYear = getParameterByName('year');
    var s = 'All Years';
    //alert("year = " + queryYear);
    var currentYear = new Date().getFullYear(); 
	var sel = document.getElementById('year');
    if (queryYear != ''){
        //sel.options.add( new Option("All Years","0"));	
        //alert("inside if!!");
        for (var i = 1; i <= 10; i++ ) {
            if(queryYear == currentYear){
            	sel.options.add( new Option(currentYear,currentYear,true,true) );	
            }else{
            	sel.options.add( new Option(currentYear,currentYear) );	
            }
        	currentYear--;
    	}
        if(queryYear == 0){
			$('.customSelectInner').html(s);
        }else{
            $('.customSelectInner').html(queryYear);
        }
    }else{
        //sel.options.add( new Option("All Years","0",true,true));
        //alert("inside else!!");
    	for (var i = 1; i <= 10; i++ ) {
			sel.options.add( new Option(currentYear,currentYear) );	
        	currentYear--;
    	}
		$('.customSelectInner').html(s);                
    }
}

    //$('#year').val(currentYear);    

</script>
<div id="selectAllTextdiv" data-selectalltextval=""></div>
<div id="selectallMsgdiv" data-selectallmsgval=""></div>
<div id="noneSelectedMsgdiv" data-noneselectedmsgval=""></div>
<div id="valueSelectedMsgdiv" data-valueselectedmsgval=""></div>

<script type="text/javascript" src="/etc/designs/nextweb/apps/components/news/clientlibs.min.js"></script>
<div id="fromdatenewsdiv" data-fromdatenewsval="18.04.2018"></div>
<div id="todatenewstdiv" data-todatenewsval="18.04.2019"></div>
<div id="reltypediv" data-reltypeval="All"></div>
<div id="attachmentlabelsdiv" data-attachmentlabelsval="en=UK,da=DK"></div>
            <div class="row">
              <div class="col-xs-12 col-sm-12 news-search-box">                
                <div class="col-sm-12 news-archive-search-box">

                    <form id="news-archive-search-box-form" name="" action="/media/novo-nordisk-news.html" method="GET" data-form-validate="true" novalidate="novalidate" class="fv-form fv-form-bootstrap"><button type="submit" class="fv-hidden-submit" style="display: none; width: 0px; height: 0px;"></button>
                    <div>
                      <div class="global-error-message hidden">
                        <p>
                        </p>
                      </div>
                      <div class="error-container">
                      </div>
					<fieldset>
                    <div class="row">
                      <div class="col-xs-12 col-sm-7">
                        <p id="newsFilter1"><span class="filter_column filter_text">
                            <input type="search" id="searchtext" name="searchtext" placeholder="Search news topic" class="search-archive-input validate-no-title" data-parsley-trigger="keyup" data-parsley-pattern="^[\s.'a-zA-Z0-9]+$" data-parsley-pattern-message="Search field may not contain special characters such as:\ / \ [ ] : | < > + = ; , ? * @ # $ % ^ &amp; ( ) { } ~ ` !" data-parsley-validation-threshold="0">
                            <label for="">
                            </label></span>
                        </p><span class="media-archive-searchicon"><i class="fa fa-search"></i></span>
                      </div>
                      <div class="col-xs-12 col-sm-3 filter-column filter-column-type">
                            <h6>Type</h6>
                            <div class="custom-select-wrapper customSelect3">
                              <select name="" data-parsley-required="false" data-parsley-required-message="" class="multiselect1" multiple="multiple" style="display: none;" data-parsley-multiple="6">
                                <option value="Press Releases" selected="selected">Press releases</option>
                                <option value="Company Announcements" selected="selected">Company announcements</option>
                                <option value="Company announcements - trading in own shares" selected="selected">Company announcements - trading in own shares</option>
                                <option value="Product-related Press Release" selected="selected">Product related</option>
                                
                              </select><div class="btn-group multiple-select-btn"><button type="button" class="multiselect customSelect customSelectInner bs-customSelect dropdown-toggle" data-toggle="dropdown">All Selected</button><ul class="multiselect-container dropdown-menu"><li class="multiselect-item multiselect-all"><a href="javascript:void(0);" class="multiselect-all"><label class="custom-checked"><input type="checkbox" name="true" value="multiselect-all" data-parsley-multiple="true"> Select All</label></a></li><li><a href="javascript:void(0);"><label class="custom-checked"><input type="checkbox" name="Press Releases" value="Press Releases" data-parsley-multiple="Press Releases"> Press releases</label></a></li><li><a href="javascript:void(0);"><label class="custom-checked"><input type="checkbox" name="Company Announcements" value="Company Announcements" data-parsley-multiple="Company Announcements"> Company announcements</label></a></li><li><a href="javascript:void(0);"><label class="custom-checked"><input type="checkbox" name="Company announcements - trading in own shares" value="Company announcements - trading in own shares" data-parsley-multiple="Company announcements - trading in own shares"> Company announcements - trading in own shares</label></a></li><li><a href="javascript:void(0);"><label class="custom-checked"><input type="checkbox" name="Product-related Press Release" value="Product-related Press Release" data-parsley-multiple="Product-related Press Release"> Product related</label></a></li></ul></div>
                            </div>
                       </div>

						<div class="col-xs-12 col-sm-2 filter-column">
                            <h6>Language</h6>
                            <div class="custom-select-wrapper customSelect3">
                           <select name="" data-parsley-required="false" data-parsley-required-message="" style="display: none;">                                                            
							<option value="en">English</option>
                             <option value="da">Danish</option>
                             
							   </select><div class="btn-group multiple-select-btn"><button type="button" class="multiselect customSelect customSelectInner bs-customSelect dropdown-toggle" data-toggle="dropdown">English </button><ul class="multiselect-container dropdown-menu" style="max-height: 200px; overflow: hidden auto;"><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="en" value="en"> English</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="da" value="da"> Danish</label></a></li></ul></div>
                            </div>
                          </div>
                    </div>
                    </fieldset>
                      <div class="row">
                        <div class="col-xs-12 col-sm-1 news-date-range"><span class="news-date-heading">Date range:</span>
                        </div>
                        <div class="col-xs-12 col-sm-5 date-range-input">
                          <div id="date-label-from" class="col-xs-6 col-sm-5">
                            <input type="text" class="date_range_filter date datepicker_from hasDatepicker" name="fromdate" id="dp1555566750279" data-fv-field="fromdate"><button type="button" class="ui-datepicker-trigger"><i class="fa fa-calendar"></i></button>
                            <label for="datepicker_from">
                            </label>
                          <small class="help-block" data-fv-validator="notEmpty" data-fv-for="fromdate" data-fv-result="VALID" style="display: none;"><div class="error">Date should not be blank</div></small><small class="help-block" data-fv-validator="date" data-fv-for="fromdate" data-fv-result="VALID" style="display: none;"><div class="error">The date is not valid. Please enter date in dd.mm.yyyy</div></small></div><span class="col-sm-1 date-range-devider hidden-xs">-</span>
                          <div id="date-label-to" class="col-xs-6 col-sm-5">
                            <input type="text" class="date_range_filter date datepicker_to hasDatepicker" name="todate" id="dp1555566750280" data-fv-field="todate"><button type="button" class="ui-datepicker-trigger"><i class="fa fa-calendar"></i></button>
                            <label for="datepicker_to">
                            </label>
                          <small class="help-block" data-fv-validator="notEmpty" data-fv-for="todate" data-fv-result="VALID" style="display: none;"><div class="error">Date should not be blank</div></small><small class="help-block" data-fv-validator="date" data-fv-for="todate" data-fv-result="VALID" style="display: none;"><div class="error">The date is not valid. Please enter date in dd.mm.yyyy</div></small></div>
                        </div>
                         <div class="col-xs-12 col-sm-2 update-button">
                            			<button type="button" tabindex="" data-toggle="" data-target="" data-dismiss="" class="col-xs-12">Search</button>
                        			</div>
                             </div>                        
                    </div>
				  </form>
                </div>
		</div>
</div>

</div>
<div class="newssearchresult parbase section"><!--<script type="text/javascript">
function SubmitDownloadForm() {
    //var searchValue = document.getElementById('searchtext').value;
    //  var yearValue = document.getElementById('year').value;
		alert(getMultidownloadPdf);
    	if (getMultidownloadPdf == '') {
            return false;
        }
        else {
            //alert("Submit form on year change !!");
            document.forms['news-archive-results-form'].submit();
            return true;                                            
        }
        return false;        
    	}
</script>  -->
<div id="maxresultsdiv" data-maxresultsval="200"></div>
<div id="dataTables-empty" data-noresultfoundval="No matching records found"></div>
<div id="newsdetailspathdiv" data-newsdetailspathval="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details"></div>
<div id="maxresultsdiv" data-maxresultsval="200"></div>
<div id="noitemsonpagediv" data-noofitemsonpageval="20"></div>
<div id="showallmsgdiv" data-showallmsgval="true"></div>
<div id="showalltextdiv" data-showalltextval="Show all"></div>
<div id="resultstextdiv" data-resultstextval="results"></div>
<div id="showingtextdiv" data-showingtextval="Showing"></div>
<div id="oftextdiv" data-oftextval="of"></div>
<div id="totextdiv" data-totextval="to"></div>
<div id="entriestextdiv" data-entriestextval="entries"></div>
<div id="showingMsgdiv" data-showingmsgval="Showing"></div>
<div id="toMsgdiv" data-tomsgval="to"></div>
<div id="ofMsgdiv" data-ofmsgval="of"></div>
<div id="entriesMsgdiv" data-entriesmsgval="entries"></div>

<div id="filteredfromtextdiv" data-filteredfromtextval="filtered from"></div>
<div id="totalentriestextdiv" data-totalentriestextval="total entries"></div>

<div id="servicejsonurldiv" data-serviceurlval="/bin/novo/searchNews"></div>

<div id="paginationprevdldiv" data-previcondlval="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-dlpx.png"></div>
<div id="paginationprevdhdiv" data-previcondhval="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-dhpx.png"></div>
<div id="paginationprevmldiv" data-previconmlval="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-mlpx.png"></div>
<div id="paginationprevmhdiv" data-previconmhval="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-mhpx.png"></div>

<div id="paginationnextdldiv" data-nexticondlval="/etc/designs/nextweb/csslibs/images/icons/pagination-next-dlpx.png"></div>
<div id="paginationnextdhdiv" data-nexticondhval="/etc/designs/nextweb/csslibs/images/icons/pagination-next-dhpx.png"></div>
<div id="paginationnextmldiv" data-nexticonmlval="/etc/designs/nextweb/csslibs/images/icons/pagination-next-mlpx.png"></div>
<div id="paginationnextmhdiv" data-nexticonmhval="/etc/designs/nextweb/csslibs/images/icons/pagination-next-mhpx.png"></div>

<div id="pdfdldiv" data-pdfdlval="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"></div>
<div id="pdfdhdiv" data-pdfdhval="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png"></div>
<div id="pdfmldiv" data-pdfmlval="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"></div>
<div id="pdfmhdiv" data-pdfmhval="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png"></div>

<div id="htmldldiv" data-htmldlval="/etc/designs/nextweb/csslibs/images/icons/ie-icon-dlpx.png"></div>
<div id="htmldhdiv" data-htmldhval="/etc/designs/nextweb/csslibs/images/icons/ie-icon-dhpx.png"></div>
<div id="htmlmldiv" data-htmlmlval="/etc/designs/nextweb/csslibs/images/icons/ie-icon-mlpx.png"></div>
<div id="htmlmhdiv" data-htmlmhval="/etc/designs/nextweb/csslibs/images/icons/ie-icon-mhpx.png"></div>

            <!-- START m7-content-divider component-->
            <hr class="content-divider line-mobile min-margin">
            <!-- END m7-content-divider component-->
            
                <!-- START f1-news-archive-results component-->
<form id="news-archive-results-form2" name="news-archive-results-form2" action="/bin/multipleDownload" method="get">
    <div class="news-archive-results-form">
        <fieldset>
                  <div id="news-archive-table_wrapper" class="dataTables_wrapper no-footer"><div class="top"><div class="dataTables_info" id="news-archive-table_info" role="status" aria-live="polite">Showing<strong> 1 </strong>to<strong> 20 </strong>of<strong> 1,017 </strong>entries </div><a href="#" class="rowCount"> </a></div><div id="news-archive-table_processing" class="dataTables_processing" style="display: none;"><i style="color:#009fda" class="fa fa-refresh fa-spin fa-3x"></i></div>
					 <table id="news-archive-table" class="display dataTable no-footer" aria-describedby="news-archive-table_info" role="grid">
						<thead>
						  <tr class="header-row" role="row"><th class="head-Name sorting_disabled" rowspan="1" colspan="1" style="width: 366px;"><br>News</th><th class="head-Date sorting_disabled" rowspan="1" colspan="1" style="width: 70px;">Date</th><th class="head-Type sorting_disabled" rowspan="1" colspan="1" style="width: 100px;">Type</th><th class="sorting_disabled" rowspan="1" colspan="1" style="width: 90px;">Download</th><th class="head-Download sorting_disabled hidden-xs" rowspan="1" colspan="1" style="width: 80px;">
								  <p>Select</p><a href="#" rel="" role="" target="" class="download-select-all">Select all</a>
							</th></tr>
						 </thead>
						<tbody>
						
							<tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2241699.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1555338521000">15 Apr 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2241699.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1555338521000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1555338521000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2241504.html">Gilead Sciences and Novo Nordisk announce intent to initiate a clinical collaboration in NASH</a></td><td><span data-order="1555059635000">12 Apr 2019<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2241504.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1555059635000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1555059635000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2241051.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1554730450000">08 Apr 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2241051.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1554730450000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1554730450000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2240294.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1554120740000">01 Apr 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2240294.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1554120740000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1554120740000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2240115.html">Novo Nordisk invests DKK 650 million in upgrading and expanding production facilities in Kalundborg</a></td><td><span data-order="1553857239000">29 Mar 2019<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2240115.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1553857239000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1553857239000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2239580.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1553521821000">25 Mar 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2239580.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1553521821000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1553521821000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2239201.html">Resolutions from the Annual General Meeting of Novo Nordisk A/S</a></td><td><span data-order="1553180294000">21 Mar 2019<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2239201.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1553180294000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1553180294000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2239031.html">Novo Nordisk files oral semaglutide for US regulatory approval of glycaemic control, as well as for CV risk reduction for oral semaglutide and Ozempic</a></td><td><span data-order="1553090387000">20 Mar 2019<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2239031.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1553090387000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1553090387000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2238924.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1552919651000">18 Mar 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2238924.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1552919651000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1552919651000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2238847.html">Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva</a></td><td><span data-order="1552906907000">18 Mar 2019<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2238847.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1552906907000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1552906907000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2238124.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1552307594000">11 Mar 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2238124.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1552307594000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1552307594000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2237231.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1551704968000">04 Mar 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2237231.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1551704968000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1551704968000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2236352.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1551101338000">25 Feb 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2236352.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1551101338000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1551101338000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2235965.html">Novo Nordisk: Notice for the Annual General Meeting of Novo Nordisk A/S  </a></td><td><span data-order="1550818889000">22 Feb 2019<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2235965.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1550818889000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1550818889000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2235735.html">Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with diabetes using insulin</a></td><td><span data-order="1550671223000">20 Feb 2019<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2235735.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1550671223000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1550671223000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2235689.html">Novo Nordisk receives US FDA approval of ESPEROCT (turoctocog alfa pegol, N8-GP)</a></td><td><span data-order="1550597370000">19 Feb 2019<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2235689.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1550597370000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1550597370000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2235477.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1550499418000">18 Feb 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2235477.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1550499418000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1550499418000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2234855.html">Trading in Novo Nordisk shares by board members, executives and associated persons on 12 February 2019</a></td><td><span data-order="1550070106000">13 Feb 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2234855.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1550070106000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1550070106000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2234423.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1549899166000">11 Feb 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2234423.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1549899166000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1549899166000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233342.html">Novo Nordisk files annual report with the SEC</a></td><td><span data-order="1549352016000">05 Feb 2019<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2233342.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1549352016000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1549352016000" class="css-label"></label></td></tr>
							<tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233355.html">Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 1 February 2019</a></td><td><span data-order="1549290849000">04 Feb 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2233355.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1549290849000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1549290849000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233033.html">Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018 </a></td><td><span data-order="1549002602000">01 Feb 2019<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2233033.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1549002602000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1549002602000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233025.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1548939063000">31 Jan 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2233025.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1548939063000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1548939063000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2232491.html">Novo Nordisk A/S: Share repurchase programme</a></td><td><span data-order="1548670330000">28 Jan 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2232491.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1548670330000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1548670330000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2231906.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1548075271000">21 Jan 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2231906.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1548075271000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1548075271000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2231270.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1547473982000">14 Jan 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2231270.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1547473982000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1547473982000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2230579.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1546863392000">07 Jan 2019<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2230579.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1546863392000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1546863392000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2229950.html">Novo Nordisk A/S: Share repurchase programme</a></td><td><span data-order="1545397452000">21 Dec 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2229950.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1545397452000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1545397452000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2229279.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1545053535000">17 Dec 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2229279.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1545053535000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1545053535000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2229220.html">Staten Biotechnology B.V. and Novo Nordisk A/S announce collaboration to develop novel treatment for dyslipidaemia</a></td><td><span data-order="1545030004000">17 Dec 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2229220.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1545030004000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1545030004000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2228448.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1544448603000">10 Dec 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2228448.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1544448603000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1544448603000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2227591.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1543843514000">03 Dec 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2227591.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1543843514000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1543843514000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226909.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1543238372000">26 Nov 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2226909.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1543238372000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1543238372000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226789.html">Oral semaglutide demonstrates favourable cardiovascular safety profile and significant reduction in cardiovascular death and all-cause mortality in people with type 2 diabetes in the PIONEER 6 trial</a></td><td><span data-order="1542985674000">23 Nov 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2226789.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1542985674000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1542985674000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226662.html">Oral semaglutide demonstrates greater reductions in both HbA1c and body weight compared to Victoza in Japanese people with type 2 diabetes</a></td><td><span data-order="1542904212000">22 Nov 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2226662.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1542904212000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1542904212000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2225865.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1542288923000">15 Nov 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2225865.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1542288923000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1542288923000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224404.html">Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2018</a></td><td><span data-order="1541518913000">06 Nov 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2224404.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1541518913000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1541518913000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224208.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1541446840000">05 Nov 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2224208.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1541446840000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1541446840000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224202.html">Novo Nordisk A/S purchases B shares worth DKK 1,262 million from Novo Holdings A/S under the 2018 share repurchase programme</a></td><td><span data-order="1541446611000">05 Nov 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2224202.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1541446611000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1541446611000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223768.html">Trading in Novo Nordisk shares by board members, executives and associated persons</a></td><td><span data-order="1541173201000">02 Nov 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2223768.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1541173201000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1541173201000" class="css-label"></label></td></tr>
							<tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223508.html">Embark and Novo Nordisk enter collaboration to discover novel therapeutics for obesity and metabolic disease</a></td><td><span data-order="1541145609000">02 Nov 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2223508.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1541145609000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1541145609000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223414.html">Novo Nordisk's operating profit decreased by 6% in Danish kroner and increased by 2% in local currencies in the first nine months of 2018</a></td><td><span data-order="1541053805000">01 Nov 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2223414.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1541053805000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1541053805000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223351.html">Novo Nordisk A/S: Share repurchase programme</a></td><td><span data-order="1540996286000">31 Oct 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2223351.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1540996286000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1540996286000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223273.html">Novo Nordisk expands its biopharm business with the acquisition of the US and Canadian rights to Macrilen(TM)</a></td><td><span data-order="1540990424000">31 Oct 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2223273.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1540990424000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1540990424000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2222176.html">Oral semaglutide demonstrates statistically significant reductions in HbA1c and body weight in people with long duration of type 2 diabetes treated with insulin</a></td><td><span data-order="1540561643000">26 Oct 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2222176.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1540561643000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1540561643000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2221504.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1540215646000">22 Oct 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2221504.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1540215646000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1540215646000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2220586.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1539611085000">15 Oct 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2220586.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1539611085000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1539611085000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2220378.html">Novo Nordisk appoints Ludovic Helfgott executive vice president Biopharm</a></td><td><span data-order="1539601201000">15 Oct 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2220378.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1539601201000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1539601201000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2219624.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1539003246000">08 Oct 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2219624.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1539003246000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1539003246000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218531.html">Addressing social and cultural drivers of type 2 diabetes is key to its treatment and prevention  </a></td><td><span data-order="1538478062000">02 Oct 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2218531.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1538478062000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1538478062000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218498.html">Novo Nordisk A/S - Share repurchase programme </a></td><td><span data-order="1538400291000">01 Oct 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2218498.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1538400291000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1538400291000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218411.html">Novo Nordisk to establish California manufacturing site for stem cell-based therapies</a></td><td><span data-order="1538384419000">01 Oct 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2218411.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1538384419000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1538384419000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218400.html">Novo Nordisk plans first global launch of connected insulin pens and announces key digital health partnerships</a></td><td><span data-order="1538380805000">01 Oct 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2218400.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1538380805000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1538380805000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217877.html">International Diabetes Federation (IDF) global survey reveals 2 in 3 people with type 2 diabetes have cardiovascular disease risk factors and/or have experienced a cardiovascular event</a></td><td><span data-order="1538125204000">28 Sep 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2217877.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1538125204000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1538125204000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217181.html">Danish Government and Novo Nordisk first to partner with UN-anchored initiative on non-communicable diseases</a></td><td><span data-order="1537806610000">24 Sep 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2217181.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1537806610000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1537806610000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217439.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1537798202000">24 Sep 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2217439.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1537798202000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1537798202000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216978.html">Novo Nordisk - Oral semaglutide demonstrates greater reductions in HbA1c and body weight and comparable number of adverse events vs dulaglutide in Japanese people with type 2 diabetes</a></td><td><span data-order="1537449358000">20 Sep 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2216978.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1537449358000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1537449358000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216603.html">Novo Nordisk announces plans to transform its approach to Research &amp; Development</a></td><td><span data-order="1537263001000">18 Sep 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2216603.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1537263001000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1537263001000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216423.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1537190895000">17 Sep 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2216423.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1537190895000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1537190895000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2215228.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1536583650000">10 Sep 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2215228.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1536583650000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1536583650000" class="css-label"></label></td></tr>
							<tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2213936.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1535979118000">03 Sep 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2213936.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1535979118000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1535979118000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2213899.html">Trading in Novo Nordisk shares by board members, executives and associated persons on 31 August 2018</a></td><td><span data-order="1535966185000">03 Sep 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2213899.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1535966185000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1535966185000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2212822.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1535376540000">27 Aug 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2212822.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1535376540000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1535376540000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2211999.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1534772720000">20 Aug 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2211999.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1534772720000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1534772720000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2211959.html">Oral semaglutide provides superior HbA1c and weight reductions versus placebo in people with type 2 diabetes and renal impairment in the PIONEER 5 trial</a></td><td><span data-order="1534758948000">20 Aug 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2211959.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1534758948000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1534758948000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2211063.html">Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins</a></td><td><span data-order="1534489279000">17 Aug 2018<span style="display:none;">en</span></span></td><td>Press Releases</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2211063.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1534489279000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1534489279000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210880.html">Trading in Novo Nordisk shares by board members, executives and associated persons on 14 August 2018</a></td><td><span data-order="1534342557000">15 Aug 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2210880.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1534342557000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1534342557000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210503.html">Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 August 2018</a></td><td><span data-order="1534165784000">13 Aug 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2210503.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1534165784000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1534165784000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210433.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1533931142000">10 Aug 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2210433.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1533931142000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1533931142000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210429.html">Novo Nordisk A/S purchases B shares worth DKK 954 million from Novo Holdings A/S under the 2018 share repurchase programme</a></td><td><span data-order="1533930508000">10 Aug 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2210429.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1533930508000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1533930508000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210156.html">Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 8 August 2018</a></td><td><span data-order="1533821821000">09 Aug 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2210156.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1533821821000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1533821821000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2209722.html">Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018</a></td><td><span data-order="1533709804000">08 Aug 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2209722.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1533709804000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1533709804000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2209678.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1533645827000">07 Aug 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2209678.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1533645827000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1533645827000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2207900.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1532953273000">30 Jul 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2207900.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1532953273000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1532953273000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2206603.html">Novo Nordisk A/S: Share repurchase programme</a></td><td><span data-order="1532340079000">23 Jul 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2206603.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1532340079000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1532340079000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2205402.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1531744549000">16 Jul 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2205402.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1531744549000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1531744549000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2203807.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1531132529000">09 Jul 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2203807.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1531132529000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1531132529000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2202534.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1530535926000">02 Jul 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2202534.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1530535926000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1530535926000" class="css-label"></label></td></tr><tr role="row" class="odd"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2201779.html">Oral semaglutide shows superior reductions in HbA1c and weight compared to sitagliptin in the long-term safety and efficacy trial, PIONEER 3  </a></td><td><span data-order="1530176849000">28 Jun 2018<span style="display:none;">en</span></span></td><td>Company Announcements</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2201779.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1530176849000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1530176849000" class="css-label"></label></td></tr><tr role="row" class="even"><td><a href="/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2201009.html">Novo Nordisk A/S - Share repurchase programme</a></td><td><span data-order="1529928205000">25 Jun 2018<span style="display:none;">en</span></span></td><td>Company announcements - trading in own shares</td><td><a class="list-link icon-medium" role="" rel="" title="" href="/bin/getPDF.2201009.pdf" id="" target="_blank"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pdf-icon-mlpx.png"><span>UK</span></a></td><td class=" hidden-xs"><input type="checkbox" id="checkbox_1529928205000" name="download-checkbox" value="" class="css-checkbox"><label for="checkbox_1529928205000" class="css-label"></label></td></tr>
							
							
							
							
						</tbody>
					</table>
						<div class="bottom">
						<div id="news-archive-table_filter" class="dataTables_filter"><label>Search:<input type="search" class="" placeholder="" aria-controls="news-archive-table"></label></div>
						<div class="dataTables_length" id="news-archive-table_length"><label>Show <select name="news-archive-table_length" aria-controls="news-archive-table" class=""><option value="20">20</option></select> entries</label></div>
						<a href="#" class="rowCount rowCount-bottom" sytle="padding-left:0px !important;"> </a>
						<div class="clearBoth"></div>
						<div class="dataTables_paginate paging_simple_numbers" id="news-archive-table_paginate"><a class="paginate_button previous disabled" aria-controls="news-archive-table" data-dt-idx="0" tabindex="0" id="news-archive-table_previous"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pagination-prev-mlpx.png"></a><span><a class="paginate_button current" aria-controls="news-archive-table" data-dt-idx="1" tabindex="0">1</a><a class="paginate_button " aria-controls="news-archive-table" data-dt-idx="2" tabindex="0">2</a><a class="paginate_button " aria-controls="news-archive-table" data-dt-idx="3" tabindex="0">3</a><a class="paginate_button " aria-controls="news-archive-table" data-dt-idx="4" tabindex="0">4</a><a class="paginate_button " aria-controls="news-archive-table" data-dt-idx="5" tabindex="0">5</a><span></span><a class="paginate_button " aria-controls="news-archive-table" data-dt-idx="6" tabindex="0">51</a></span><a class="paginate_button next" aria-controls="news-archive-table" data-dt-idx="7" tabindex="0" id="news-archive-table_next"><img class="img img-responsive js-image-responsive" role="presentation" title="" alt="" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/pagination-next-dhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/pagination-next-dlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/pagination-next-mhpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/pagination-next-mlpx.png" src="/etc/designs/nextweb/csslibs/images/icons/pagination-next-mlpx.png"></a></div></div><div class="clear"></div></div>
         </fieldset>
<!-- START c17-modal component-->
                    <div id="news-disclaimer-popup" aria-hidden="true" aria-labelledby="news-disclaimer-popup" class="modal" tabindex="-1" role="dialog">
                      <div class="modal-dialog">
                        <div class="modal-content"><a href="#" rel="" role="" target="" class="close-modal" data-dismiss="modal" aria-hidden="true"><img src="/etc/designs/nextweb/csslibs/images/icons/modal-close-mlpx.png" data-xssrc="/etc/designs/nextweb/csslibs/images/icons/modal-close-mlpx.png" data-hdxssrc="/etc/designs/nextweb/csslibs/images/icons/modal-close-mhpx.png" data-mdsrc="/etc/designs/nextweb/csslibs/images/icons/modal-close-dlpx.png" data-hdmdsrc="/etc/designs/nextweb/csslibs/images/icons/modal-close-dhpx.png" alt="" title="" role="presentation" class="img img-responsive js-image-responsive"></a>
                          <div class="modal-body">
                            <div class="step1x">
                              <p>Select the country in which you reside:
                              </p>
                              <div class="custom-select-wrapper customSelect3">
                                <select id="ddlcounty1x" name="" data-parsley-required="false" data-parsley-required-message="" style="display: none;">
                                  <option value="Select" selected="selected" disabled="disabled">Select
                                  </option>
                                  <option value="Denmark">Denmark
                                  </option>
                                  <option value="Rest of EU/EEA">Rest of EU/EEA
                                  </option>
                                  <option value="United States of America">United States of America
                                  </option>
                                  <option value="Australia">Australia
                                  </option>
                                  <option value="Canada">Canada
                                  </option>
                                  <option value="Japan">Japan
                                  </option>
                                  <option value="Rest of the world (excluding EU/EEA)">Rest of the world (excluding EU/EEA)
                                  </option>
                                  
                                </select><div class="btn-group multiple-select-btn"><button type="button" class="multiselect customSelect customSelectInner bs-customSelect dropdown-toggle" data-toggle="dropdown">Select
                                   </button><ul class="multiselect-container dropdown-menu" style="max-height: 200px; overflow: hidden auto;"><li class="disabled"><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')" tabindex="-1"><label class="radio"><input type="radio" name="Select" value="Select" disabled=""> Select
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Denmark" value="Denmark"> Denmark
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Rest of EU/EEA" value="Rest of EU/EEA"> Rest of EU/EEA
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="United States of America" value="United States of America"> United States of America
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Australia" value="Australia"> Australia
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Canada" value="Canada"> Canada
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Japan" value="Japan"> Japan
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Rest of the world (excluding EU/EEA)" value="Rest of the world (excluding EU/EEA)"> Rest of the world (excluding EU/EEA)
                                  </label></a></li></ul></div>
                              </div>
                              <p>Enter the country in which you are currently physically present:
                              </p>
                              <div class="custom-select-wrapper customSelect3">
                                <select id="ddlcounty2x" name="" data-parsley-required="false" data-parsley-required-message="" style="display: none;">
                                  <option value="Select" selected="selected" disabled="disabled">Select
                                  </option>
                                  <option value="Denmark">Denmark
                                  </option>
                                  <option value="Rest of EU/EEA">Rest of EU/EEA
                                  </option>
                                  <option value="United States of America">United States of America
                                  </option>
                                  <option value="Australia">Australia
                                  </option>
                                  <option value="Canada">Canada
                                  </option>
                                  <option value="Japan">Japan
                                  </option>
                                  <option value="Rest of the world (excluding EU/EEA)">Rest of the world (excluding EU/EEA)
                                  </option>
                                  
                                </select><div class="btn-group multiple-select-btn"><button type="button" class="multiselect customSelect customSelectInner bs-customSelect dropdown-toggle" data-toggle="dropdown">Select
                                   </button><ul class="multiselect-container dropdown-menu" style="max-height: 200px; overflow: hidden auto;"><li class="disabled"><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')" tabindex="-1"><label class="radio"><input type="radio" name="Select" value="Select" disabled=""> Select
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Denmark" value="Denmark"> Denmark
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Rest of EU/EEA" value="Rest of EU/EEA"> Rest of EU/EEA
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="United States of America" value="United States of America"> United States of America
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Australia" value="Australia"> Australia
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Canada" value="Canada"> Canada
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Japan" value="Japan"> Japan
                                  </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Rest of the world (excluding EU/EEA)" value="Rest of the world (excluding EU/EEA)"> Rest of the world (excluding EU/EEA)
                                  </label></a></li></ul></div>
                              </div>
                              <div class="button-verify">
                                <button id="step1xbtn" type="button" tabindex="" disabled="disabled" data-toggle="" data-target="" data-dismiss="" class="button">Verify
                                </button>
                              </div>
                              <div class="clearBoth">
                              </div>
                            </div>
                            <div class="step2x hidden">
                              <p>The information contained in this section of the website of Novo Nordisk A/S (the "Company") is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the "United States"), Australia, Canada, or Japan, or any jurisdiction where to do so might constitute a violation of the securities laws or regulations of such jurisdiction, and does not constitute an offer to sell or the solicitation of an offer to buy or acquire, any ordinary shares or other securities of the Company in the United States, Australia, Canada, Japan, or any other jurisdiction in which such release, publication or distribution  would be unlawful or would require registration or other measures.</p>
                              <p>The shares of the Company referred to in this section of the website (the "Shares") have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States absent registration or in certain transactions exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. Furthermore, the Shares have not been and will not be registered under the applicable securities laws of Australia, Canada, Japan, or any other jurisdiction in which it would be unlawful or would require registration or other measures, and therefore may not be offered or sold or for the account or benefit of any person having a registered address in, or located or resident in, Australia, Canada, Japan or any other jurisdiction in which it  would be unlawful or would require registration or other measures.</p>
                              <p>Access to the information and documents contained on the following section of the Company's website may be illegal in certain jurisdictions, and only certain categories of persons may be authorised to access such information and documents.  All persons residing outside of Denmark who wish to have access to the documents contained in this section of the Company's website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this section of the website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been or will be obtained outside Denmark. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.</p>
                              <p>The use of this section of the website is subject to Danish law and any disputes arising out of or regarding this section of the website is subject to Danish law and the exclusive jurisdictions of the Danish courts.</p>
                              <p>I therefore certify that: <br>1.I am resident and physically present in a country outside the United States, Australia, Canada, and Japan; and <br>2.I am authorised to access the information and documents on this section of the website without being subject to any legal restrictions and without any further action required by the Company.
                              </p>
                              <p>
                              </p>
                              <p>
                                </p><div class="custom-select-wrapper customSelect3">
                                  <select id="cert1x" name="" data-parsley-required="false" data-parsley-required-message="" style="display: none;">
                                    <option value="Select" disabled="disabled">Select
                                    </option>
                                    <option value="Yes">Yes
                                    </option>
                                    <option value="No">No
                                    </option>
                                    
                                  </select><div class="btn-group multiple-select-btn"><button type="button" class="multiselect customSelect customSelectInner bs-customSelect dropdown-toggle" data-toggle="dropdown">Yes
                                     </button><ul class="multiselect-container dropdown-menu" style="max-height: 200px; overflow: hidden auto;"><li class="disabled"><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')" tabindex="-1"><label class="radio"><input type="radio" name="Select" value="Select" disabled=""> Select
                                    </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Yes" value="Yes"> Yes
                                    </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="No" value="No"> No
                                    </label></a></li></ul></div>
                                </div>
                              <p></p>
                              <p>I have read, understand and agree to comply with all of the restrictions set forth above.
                              </p>
                              <p>
                                </p><div class="custom-select-wrapper customSelect3">
                                  <select id="cert2x" name="" data-parsley-required="false" data-parsley-required-message="" style="display: none;">
                                    <option value="Select" disabled="disabled">Select
                                    </option>
                                    <option value="Yes">Yes
                                    </option>
                                    <option value="No">No
                                    </option>
                                    
                                  </select><div class="btn-group multiple-select-btn"><button type="button" class="multiselect customSelect customSelectInner bs-customSelect dropdown-toggle" data-toggle="dropdown">Yes
                                     </button><ul class="multiselect-container dropdown-menu" style="max-height: 200px; overflow: hidden auto;"><li class="disabled"><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')" tabindex="-1"><label class="radio"><input type="radio" name="Select" value="Select" disabled=""> Select
                                    </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="Yes" value="Yes"> Yes
                                    </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="No" value="No"> No
                                    </label></a></li></ul></div>
                                </div>
                              <p></p>
                              <div class="button-verify">
                                <button id="step2xbtn" type="button" tabindex="" disabled="disabled" data-toggle="" data-target="" data-dismiss="" class="button">Verify
                                </button>
                              </div>
                              <div class="clearBoth">
                              </div>
                            </div>
                            <div class="step3x hidden">
                              <h4>
                              </h4><a href="#" rel="" role="" target="" class="english-link"></a><br><a href="#" rel="" role="" target="" class="danish-link"></a>
                              <div class="step3x-disclaimer-content">
                                <p>THE ACCESS TO THE INFORMATION AND DOCUMENTS CONTAINED IN THIS SECTION OF THE WEBSITE OF NOVO NORDISK A/S (THE "COMPANY") IS LIMITED TO PERSONS RESIDENT AND PHYSICALLY PRESENT IN DENMARK AND TO AUTHORISED PERSONS WHO ARE RESIDENT AND PHYSICALLY PRESENT IN CERTAIN OTHER JURISDICTIONS. THE INFORMATION IS MADE AVAILABLE IN  CONNECTION WITH THE INITIAL PUBLIC OFFERING OF SHARES IN THE COMPANY WHICH COMPRISES (I) A PUBLIC OFFERING TO RETAIL AND INSTITUTIONAL INVESTORS IN DENMARK, (II) A PRIVATE PLACEMENT IN THE UNITED STATES ONLY TO PERSONS WHO ARE "QUALIFIED INSTITUTIONAL BUYERS" OR "QIBS" (AS DEFINED IN RULE 144A UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) IN RELIANCE ON RULE 144A, AND (III) PRIVATE PLACEMENTS TO INSTITUTIONAL INVESTORS IN CERTAIN OTHER JURISDICTIONS. THE OFFERING OUTSIDE THE UNITED STATES WILL BE MADE IN COMPLIANCE WITH REGULATION S UNDER THE SECURITIES ACT. THE INFORMATION AND DOCUMENTS MUST NOT BE ACCESSED, COPIED OR DOWNLOADED, IN WHOLE OR IN PART, BY PERSONS PRESENT OR RESIDENT IN ANY JURISDICTION WHERE AN OFFER TO SELL OR A SOLICITATION OF ANY OFFER TO BUY ANY SECURITIES ISSUED BY THE COMPANY WOULD BE UNLAWFUL AND THE INFORMATION AND DOCUMENTS CONTAINED HEREIN ARE NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO SUCH JURISDICTIONS.</p>
                                <p>All persons residing outside of Denmark who wish to have access to the information and the documents contained in this section of the Company's website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this section of the website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been or will be obtained outside Denmark. The Company assumes no responsibility if there is a violation of applicable law or regulations by any person. In any member state of the European Economic Area ("EEA member state"), other than Denmark, that has implemented Directive 2003/71/EC as amended (together with any applicable implementing measures in any member state, the "Prospectus Directive"), the information and the documents contained in this section of the Company's website are only addressed to and is only directed at investors in that EEA Member State who fulfil the criteria for exemption from the obligation to publish an offering circular, including qualified investors within the meaning of the Prospectus Directive as implemented in each such EEA Member State.</p>
                                <p>Any securities referred to in this section of the Company's website have not been and will not be registered under the Securities Act, and may not be offered or sold in the United States absent registration or an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.  There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.  Any securities sold in the United States will be sold only to qualified institutional buyers (as defined in Rule 144A under the Securities Act) pursuant to Rule 144A.</p>
                                <p>In the United Kingdom, the information and the documents contained in this section of the Company's website are only being distributed to, and are only directed at, and any investment or investment activity to which this section of the Company's website relates is available only to, and will be engaged in only with, "qualified investors" (as defined in section 86(7) of the Financial Services and Markets Act 2000) and who are (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons").  Persons who are not relevant persons should not take any action on the basis of the information and the documents contained in this section of the Company's website and should not act or rely on them.</p>
                                <p>THE CONTENTS OF THIS SECTION OF THE WEBSITE ARE NOT TO BE INCORPORATED INTO, OR CONSTRUED TO FORM PART OF, ANY OF THE DOCUMENTS INCLUDED HEREIN.  EXCEPT AS OTHERWISE EXPLICITLY STATED HEREIN AS APPLICABLE TO THEM, NO INFORMATION INCLUDED ON THIS SECTION OF THE WEBSITE SHOULD BE USED BY INVESTORS IN FORMING THEIR INVESTMENT DECISION AS TO ANY SECURITIES.</p>
                              </div>
                              <div class="button-verify">
                                <button id="step3xbtn" type="button" tabindex="" data-toggle="" data-target="" data-dismiss="modal" class="button" aria-hidden="true">Close
                                </button>
                              </div>
                              <div class="clearBoth">
                              </div>
                            </div>
                            <div class="NonEuStepfailedx hidden">
                              <p>The information contained in this section of the website of Novo Nordisk A/S (the "Company") is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the "United States"), Australia, Canada, Japan, or any other jurisdiction in which such release, publication or distribution  would be unlawful or would require registration or other measures.</p>
                              <div class="button-verify">
                                <button id="step4xbtn" type="button" tabindex="" data-toggle="" data-target="" data-dismiss="modal" class="button" aria-hidden="true">Close
                                </button>
                              </div>
                              <div class="clearBoth">
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                    <!-- END c17-modal component-->         
                  	<div class="row download-selected-row hidden-xs" style="bottom: 0px;">                    
                        <div class="col-sm-12">
                      <button type="submit" tabindex="" data-toggle="" data-target="" data-dismiss="" class="download-selected">Download Selected</button>
                    </div>
   					</div>                  
    </div>
					<input type="hidden" class="passgeturl" name="PDFvalues" value="/bin/getPDF.2200408.pdf,/bin/getPDF.2199723.pdf,/bin/getPDF.2199808.pdf,/bin/getPDF.2198480.pdf,/bin/getPDF.2197024.pdf,/bin/getPDF.2195846.pdf,/bin/getPDF.2195587.pdf,/bin/getPDF.2194505.pdf,/bin/getPDF.2193101.pdf,/bin/getPDF.2192430.pdf,/bin/getPDF.2191519.pdf,/bin/getPDF.2191209.pdf,/bin/getPDF.2190836.pdf,/bin/getPDF.2190633.pdf,/bin/getPDF.2190629.pdf,/bin/getPDF.2190148.pdf,/bin/getPDF.2189261.pdf,/bin/getPDF.2189251.pdf,/bin/getPDF.2187312.pdf,/bin/getPDF.2189084.pdf,">

</form>
                <!-- END f1-news-archive-results component-->
<script>var newsItems = $.parseJSON('[{"releaseDate":"15 Apr 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2241699.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2241699.html","releaseDateTimeStamp":1555338521000},{"releaseDate":"12 Apr 2019","language":"en","title":"Gilead Sciences and Novo Nordisk announce intent to initiate a clinical collaboration in NASH","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2241504.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2241504.html","releaseDateTimeStamp":1555059635000},{"releaseDate":"08 Apr 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2241051.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2241051.html","releaseDateTimeStamp":1554730450000},{"releaseDate":"01 Apr 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2240294.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2240294.html","releaseDateTimeStamp":1554120740000},{"releaseDate":"29 Mar 2019","language":"en","title":"Novo Nordisk invests DKK 650 million in upgrading and expanding production facilities in Kalundborg","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2240115.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2240115.html","releaseDateTimeStamp":1553857239000},{"releaseDate":"29 Mar 2019","language":"da","title":"Novo Nordisk investerer 650 mio. kr. i optimering og udvidelse af produktionsfaciliteterne i Kalundborg","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2240116.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2240116.html","releaseDateTimeStamp":1553857239000},{"releaseDate":"25 Mar 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2239580.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2239580.html","releaseDateTimeStamp":1553521821000},{"releaseDate":"21 Mar 2019","language":"en","title":"Resolutions from the Annual General Meeting of Novo Nordisk A/S","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2239201.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2239201.html","releaseDateTimeStamp":1553180294000},{"releaseDate":"20 Mar 2019","language":"en","title":"Novo Nordisk files oral semaglutide for US regulatory approval of glycaemic control, as well as for CV risk reduction for oral semaglutide and Ozempic","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2239031.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2239031.html","releaseDateTimeStamp":1553090387000},{"releaseDate":"18 Mar 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2238924.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2238924.html","releaseDateTimeStamp":1552919651000},{"releaseDate":"18 Mar 2019","language":"en","title":"Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2238847.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2238847.html","releaseDateTimeStamp":1552906907000},{"releaseDate":"11 Mar 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2238124.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2238124.html","releaseDateTimeStamp":1552307594000},{"releaseDate":"04 Mar 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2237231.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2237231.html","releaseDateTimeStamp":1551704968000},{"releaseDate":"25 Feb 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2236352.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2236352.html","releaseDateTimeStamp":1551101338000},{"releaseDate":"22 Feb 2019","language":"en","title":"Novo Nordisk: Notice for the Annual General Meeting of Novo Nordisk A/S  ","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2235965.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2235965.html","releaseDateTimeStamp":1550818889000},{"releaseDate":"20 Feb 2019","language":"en","title":"Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with diabetes using insulin","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2235735.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2235735.html","releaseDateTimeStamp":1550671223000},{"releaseDate":"19 Feb 2019","language":"en","title":"Novo Nordisk receives US FDA approval of ESPEROCT (turoctocog alfa pegol, N8-GP)","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2235689.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2235689.html","releaseDateTimeStamp":1550597370000},{"releaseDate":"18 Feb 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2235477.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2235477.html","releaseDateTimeStamp":1550499418000},{"releaseDate":"13 Feb 2019","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons on 12 February 2019","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2234855.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2234855.html","releaseDateTimeStamp":1550070106000},{"releaseDate":"11 Feb 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2234423.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2234423.html","releaseDateTimeStamp":1549899166000},{"releaseDate":"05 Feb 2019","language":"en","title":"Novo Nordisk files annual report with the SEC","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2233342.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233342.html","releaseDateTimeStamp":1549352016000},{"releaseDate":"04 Feb 2019","language":"en","title":"Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 1 February 2019","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2233355.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233355.html","releaseDateTimeStamp":1549290849000},{"releaseDate":"04 Feb 2019","language":"da","title":"Novo Nordisk A/S: Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 1. februar 2019","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2233356.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233356.html","releaseDateTimeStamp":1549290849000},{"releaseDate":"01 Feb 2019","language":"en","title":"Novo Nordisk\u0027s operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018 ","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2233033.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233033.html","releaseDateTimeStamp":1549002602000},{"releaseDate":"01 Feb 2019","language":"da","title":"Novo Nordisks resultat af primr drift faldt med 4% opgjort i kroner og steg med 3% i lokale valutaer i 2018","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2233034.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233034.html","releaseDateTimeStamp":1549002602000},{"releaseDate":"31 Jan 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2233025.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233025.html","releaseDateTimeStamp":1548939063000},{"releaseDate":"31 Jan 2019","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2233026.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2233026.html","releaseDateTimeStamp":1548939063000},{"releaseDate":"28 Jan 2019","language":"en","title":"Novo Nordisk A/S: Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2232491.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2232491.html","releaseDateTimeStamp":1548670330000},{"releaseDate":"28 Jan 2019","language":"da","title":"Novo Nordisk A/S: aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2232492.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2232492.html","releaseDateTimeStamp":1548670330000},{"releaseDate":"21 Jan 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2231906.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2231906.html","releaseDateTimeStamp":1548075271000},{"releaseDate":"21 Jan 2019","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2231907.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2231907.html","releaseDateTimeStamp":1548075271000},{"releaseDate":"14 Jan 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2231270.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2231270.html","releaseDateTimeStamp":1547473982000},{"releaseDate":"14 Jan 2019","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2231271.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2231271.html","releaseDateTimeStamp":1547473982000},{"releaseDate":"07 Jan 2019","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2230579.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2230579.html","releaseDateTimeStamp":1546863392000},{"releaseDate":"07 Jan 2019","language":"da","title":"Novo Nordisk A/S: aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2230580.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2230580.html","releaseDateTimeStamp":1546863392000},{"releaseDate":"21 Dec 2018","language":"en","title":"Novo Nordisk A/S: Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2229950.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2229950.html","releaseDateTimeStamp":1545397452000},{"releaseDate":"21 Dec 2018","language":"da","title":"Novo Nordisk A/S: aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2229951.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2229951.html","releaseDateTimeStamp":1545397452000},{"releaseDate":"17 Dec 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2229279.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2229279.html","releaseDateTimeStamp":1545053535000},{"releaseDate":"17 Dec 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2229280.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2229280.html","releaseDateTimeStamp":1545053535000},{"releaseDate":"17 Dec 2018","language":"en","title":"Staten Biotechnology B.V. and Novo Nordisk A/S announce collaboration to develop novel treatment for dyslipidaemia","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2229220.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2229220.html","releaseDateTimeStamp":1545030004000},{"releaseDate":"10 Dec 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2228448.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2228448.html","releaseDateTimeStamp":1544448603000},{"releaseDate":"10 Dec 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2228449.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2228449.html","releaseDateTimeStamp":1544448603000},{"releaseDate":"03 Dec 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2227591.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2227591.html","releaseDateTimeStamp":1543843514000},{"releaseDate":"03 Dec 2018","language":"da","title":"Novo Nordisk A/S: aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2227592.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2227592.html","releaseDateTimeStamp":1543843514000},{"releaseDate":"26 Nov 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2226909.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226909.html","releaseDateTimeStamp":1543238372000},{"releaseDate":"26 Nov 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2226910.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226910.html","releaseDateTimeStamp":1543238372000},{"releaseDate":"23 Nov 2018","language":"en","title":"Oral semaglutide demonstrates favourable cardiovascular safety profile and significant reduction in cardiovascular death and all-cause mortality in people with type 2 diabetes in the PIONEER 6 trial","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2226789.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226789.html","releaseDateTimeStamp":1542985674000},{"releaseDate":"23 Nov 2018","language":"da","title":"Oral semaglutid viser en positiv kardiovaskulr sikkerhedsprofil og en signifikant reduktion i hjerte-kar-ddsfald og den samlede ddelighed hos mennesker med type 2-diabetes i PIONEER 6-studiet","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2226790.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226790.html","releaseDateTimeStamp":1542985674000},{"releaseDate":"22 Nov 2018","language":"en","title":"Oral semaglutide demonstrates greater reductions in both HbA1c and body weight compared to Victoza in Japanese people with type 2 diabetes","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2226662.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226662.html","releaseDateTimeStamp":1542904212000},{"releaseDate":"22 Nov 2018","language":"da","title":"Oral semaglutid giver strre reduktioner i bde langtidsblodsukker og vgt sammenlignet med Victoza hos japanere med type 2-diabetes","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2226663.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2226663.html","releaseDateTimeStamp":1542904212000},{"releaseDate":"15 Nov 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2225865.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2225865.html","releaseDateTimeStamp":1542288923000},{"releaseDate":"15 Nov 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2225866.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2225866.html","releaseDateTimeStamp":1542288923000},{"releaseDate":"06 Nov 2018","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2224404.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224404.html","releaseDateTimeStamp":1541518913000},{"releaseDate":"06 Nov 2018","language":"da","title":"Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 5. november 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2224405.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224405.html","releaseDateTimeStamp":1541518913000},{"releaseDate":"05 Nov 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2224208.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224208.html","releaseDateTimeStamp":1541446840000},{"releaseDate":"05 Nov 2018","language":"da","title":"Novo Nordisk A/S - Aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2224209.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224209.html","releaseDateTimeStamp":1541446840000},{"releaseDate":"05 Nov 2018","language":"en","title":"Novo Nordisk A/S purchases B shares worth DKK 1,262 million from Novo Holdings A/S under the 2018 share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2224202.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224202.html","releaseDateTimeStamp":1541446611000},{"releaseDate":"05 Nov 2018","language":"da","title":"Novo Nordisk A/S kber B-aktier til en vrdi af 1.262 mio. kr. fra Novo Holdings A/S som led i det samlede aktietilbagekbsprogram for 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2224203.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2224203.html","releaseDateTimeStamp":1541446611000},{"releaseDate":"02 Nov 2018","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2223768.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223768.html","releaseDateTimeStamp":1541173201000},{"releaseDate":"02 Nov 2018","language":"da","title":"Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier ","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2223769.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223769.html","releaseDateTimeStamp":1541173201000},{"releaseDate":"02 Nov 2018","language":"en","title":"Embark and Novo Nordisk enter collaboration to discover novel therapeutics for obesity and metabolic disease","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2223508.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223508.html","releaseDateTimeStamp":1541145609000},{"releaseDate":"01 Nov 2018","language":"en","title":"Novo Nordisk\u0027s operating profit decreased by 6% in Danish kroner and increased by 2% in local currencies in the first nine months of 2018","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2223414.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223414.html","releaseDateTimeStamp":1541053805000},{"releaseDate":"01 Nov 2018","language":"da","title":"Novo Nordisks resultat af primr drift faldt med 6% opgjort i kroner og steg med 2% i lokale valutaer i de frste ni mneder af 2018","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2223415.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223415.html","releaseDateTimeStamp":1541053805000},{"releaseDate":"31 Oct 2018","language":"en","title":"Novo Nordisk A/S: Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2223351.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223351.html","releaseDateTimeStamp":1540996286000},{"releaseDate":"31 Oct 2018","language":"da","title":"Novo Nordisk A/S: ktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2223352.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223352.html","releaseDateTimeStamp":1540996286000},{"releaseDate":"31 Oct 2018","language":"en","title":"Novo Nordisk expands its biopharm business with the acquisition of the US and Canadian rights to Macrilen(TM)","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2223273.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223273.html","releaseDateTimeStamp":1540990424000},{"releaseDate":"31 Oct 2018","language":"da","title":"Novo Nordisk udvider sin biopharm-forretning med kb af de amerikanske og canadiske rettigheder til Macrilen(TM)","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2223274.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2223274.html","releaseDateTimeStamp":1540990424000},{"releaseDate":"26 Oct 2018","language":"en","title":"Oral semaglutide demonstrates statistically significant reductions in HbA1c and body weight in people with long duration of type 2 diabetes treated with insulin","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2222176.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2222176.html","releaseDateTimeStamp":1540561643000},{"releaseDate":"26 Oct 2018","language":"da","title":"Oral semaglutid giver statistisk signifikante reduktioner i langtidsblodsukker og vgt hos mennesker, som lnge har haft type 2-diabetes og fr insulinbehandling","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2222177.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2222177.html","releaseDateTimeStamp":1540561643000},{"releaseDate":"22 Oct 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2221504.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2221504.html","releaseDateTimeStamp":1540215646000},{"releaseDate":"22 Oct 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2221505.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2221505.html","releaseDateTimeStamp":1540215646000},{"releaseDate":"15 Oct 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2220586.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2220586.html","releaseDateTimeStamp":1539611085000},{"releaseDate":"15 Oct 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2220587.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2220587.html","releaseDateTimeStamp":1539611085000},{"releaseDate":"15 Oct 2018","language":"en","title":"Novo Nordisk appoints Ludovic Helfgott executive vice president Biopharm","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2220378.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2220378.html","releaseDateTimeStamp":1539601201000},{"releaseDate":"15 Oct 2018","language":"da","title":"Novo Nordisk udnvner Ludovic Helfgott til koncerndirektr for Biopharm","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2220379.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2220379.html","releaseDateTimeStamp":1539601201000},{"releaseDate":"08 Oct 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2219624.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2219624.html","releaseDateTimeStamp":1539003246000},{"releaseDate":"08 Oct 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2219625.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2219625.html","releaseDateTimeStamp":1539003246000},{"releaseDate":"02 Oct 2018","language":"en","title":"Addressing social and cultural drivers of type 2 diabetes is key to its treatment and prevention  ","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2218531.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218531.html","releaseDateTimeStamp":1538478062000},{"releaseDate":"01 Oct 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme ","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2218498.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218498.html","releaseDateTimeStamp":1538400291000},{"releaseDate":"01 Oct 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2218499.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218499.html","releaseDateTimeStamp":1538400291000},{"releaseDate":"01 Oct 2018","language":"en","title":"Novo Nordisk to establish California manufacturing site for stem cell-based therapies","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2218411.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218411.html","releaseDateTimeStamp":1538384419000},{"releaseDate":"01 Oct 2018","language":"da","title":"Novo Nordisk etablerer produktionsanlg i Californien til fremstilling af stamcellebaseret behandling","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2218412.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218412.html","releaseDateTimeStamp":1538384419000},{"releaseDate":"01 Oct 2018","language":"en","title":"Novo Nordisk plans first global launch of connected insulin pens and announces key digital health partnerships","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2218400.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218400.html","releaseDateTimeStamp":1538380805000},{"releaseDate":"01 Oct 2018","language":"da","title":"Novo Nordisk planlgger frste globale lancering af intelligente insulinpenne og annoncerer vigtige partnerskaber indenfor digital sundhed","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2218401.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218401.html","releaseDateTimeStamp":1538380805000},{"releaseDate":"28 Sep 2018","language":"en","title":"International Diabetes Federation (IDF) global survey reveals 2 in 3 people with type 2 diabetes have cardiovascular disease risk factors and/or have experienced a cardiovascular event","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2217877.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217877.html","releaseDateTimeStamp":1538125204000},{"releaseDate":"28 Sep 2018","language":"da","title":"Global undersgelse viser, at 2 ud af 3 med type 2-diabetes har risikofaktorer for hjerte-kar-sygdom og/eller har haft et hjerte-kar-tilflde  ","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2217878.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217878.html","releaseDateTimeStamp":1538125204000},{"releaseDate":"24 Sep 2018","language":"en","title":"Danish Government and Novo Nordisk first to partner with UN-anchored initiative on non-communicable diseases","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2217181.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217181.html","releaseDateTimeStamp":1537806610000},{"releaseDate":"24 Sep 2018","language":"da","title":"Den danske regering og Novo Nordisk indgr partnerskab med FN-forankret initiativ til bekmpelse af ikke-smitsomme sygdomme","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2217182.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217182.html","releaseDateTimeStamp":1537806610000},{"releaseDate":"24 Sep 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2217439.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217439.html","releaseDateTimeStamp":1537798202000},{"releaseDate":"24 Sep 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2217440.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2217440.html","releaseDateTimeStamp":1537798202000},{"releaseDate":"20 Sep 2018","language":"en","title":"Novo Nordisk - Oral semaglutide demonstrates greater reductions in HbA1c and body weight and comparable number of adverse events vs dulaglutide in Japanese people with type 2 diabetes","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2216978.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216978.html","releaseDateTimeStamp":1537449358000},{"releaseDate":"20 Sep 2018","language":"da","title":"Novo Nordisk - Oral semaglutid viser strre reduktioner i langtidsblodsukker og vgt og et sammenligneligt antal bivirkninger sammenlignet med dulaglutid hos japanere med type 2-diabetes","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2216979.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216979.html","releaseDateTimeStamp":1537449358000},{"releaseDate":"18 Sep 2018","language":"en","title":"Novo Nordisk announces plans to transform its approach to Research \u0026 Development","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2216603.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216603.html","releaseDateTimeStamp":1537263001000},{"releaseDate":"18 Sep 2018","language":"da","title":"Novo Nordisk annoncerer planer om markante ndringer i tilgangen til forskning og udvikling","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2216604.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216604.html","releaseDateTimeStamp":1537263001000},{"releaseDate":"17 Sep 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2216423.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216423.html","releaseDateTimeStamp":1537190895000},{"releaseDate":"17 Sep 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2216424.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2216424.html","releaseDateTimeStamp":1537190895000},{"releaseDate":"10 Sep 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2215228.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2215228.html","releaseDateTimeStamp":1536583650000},{"releaseDate":"10 Sep 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2215229.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2215229.html","releaseDateTimeStamp":1536583650000},{"releaseDate":"03 Sep 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2213936.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2213936.html","releaseDateTimeStamp":1535979118000},{"releaseDate":"03 Sep 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2213937.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2213937.html","releaseDateTimeStamp":1535979118000},{"releaseDate":"03 Sep 2018","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons on 31 August 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2213899.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2213899.html","releaseDateTimeStamp":1535966185000},{"releaseDate":"03 Sep 2018","language":"da","title":"Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 31. august 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2213900.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2213900.html","releaseDateTimeStamp":1535966185000},{"releaseDate":"27 Aug 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2212822.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2212822.html","releaseDateTimeStamp":1535376540000},{"releaseDate":"27 Aug 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2212823.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2212823.html","releaseDateTimeStamp":1535376540000},{"releaseDate":"20 Aug 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2211999.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2211999.html","releaseDateTimeStamp":1534772720000},{"releaseDate":"20 Aug 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2212000.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2212000.html","releaseDateTimeStamp":1534772720000},{"releaseDate":"20 Aug 2018","language":"en","title":"Oral semaglutide provides superior HbA1c and weight reductions versus placebo in people with type 2 diabetes and renal impairment in the PIONEER 5 trial","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2211959.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2211959.html","releaseDateTimeStamp":1534758948000},{"releaseDate":"20 Aug 2018","language":"da","title":"Oral semaglutid giver strre reduktioner i langtidsblodsukker og vgt sammenlignet med placebo hos mennesker med type 2-diabetes og nedsat nyrefunktion i PIONEER 5-studiet","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2211960.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2211960.html","releaseDateTimeStamp":1534758948000},{"releaseDate":"17 Aug 2018","language":"en","title":"Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2211063.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2211063.html","releaseDateTimeStamp":1534489279000},{"releaseDate":"17 Aug 2018","language":"da","title":"Novo Nordisk kber Ziylo Ltd med det forml at fremskynde udviklingen af glukoseresponsive insuliner","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2211064.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2211064.html","releaseDateTimeStamp":1534489279000},{"releaseDate":"15 Aug 2018","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons on 14 August 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2210880.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210880.html","releaseDateTimeStamp":1534342557000},{"releaseDate":"15 Aug 2018","language":"da","title":"Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 14. august 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2210881.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210881.html","releaseDateTimeStamp":1534342557000},{"releaseDate":"13 Aug 2018","language":"en","title":"Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 August 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2210503.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210503.html","releaseDateTimeStamp":1534165784000},{"releaseDate":"13 Aug 2018","language":"da","title":"Novo Nordisk A/S: Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 10. august 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2210504.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210504.html","releaseDateTimeStamp":1534165784000},{"releaseDate":"10 Aug 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2210433.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210433.html","releaseDateTimeStamp":1533931142000},{"releaseDate":"10 Aug 2018","language":"da","title":"Novo Nordisk A/S - Aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2210434.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210434.html","releaseDateTimeStamp":1533931142000},{"releaseDate":"10 Aug 2018","language":"en","title":"Novo Nordisk A/S purchases B shares worth DKK 954 million from Novo Holdings A/S under the 2018 share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2210429.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210429.html","releaseDateTimeStamp":1533930508000},{"releaseDate":"10 Aug 2018","language":"da","title":"Novo Nordisk A/S kber B-aktier til en vrdi af 954 mio. kr. fra Novo Holdings A/S som led i det samlede aktietilbagekbsprogram for 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2210430.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210430.html","releaseDateTimeStamp":1533930508000},{"releaseDate":"09 Aug 2018","language":"en","title":"Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 8 August 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2210156.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210156.html","releaseDateTimeStamp":1533821821000},{"releaseDate":"09 Aug 2018","language":"da","title":"Novo Nordisk A/S: Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 8. august 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2210157.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2210157.html","releaseDateTimeStamp":1533821821000},{"releaseDate":"08 Aug 2018","language":"en","title":"Novo Nordisk\u0027s operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2209722.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2209722.html","releaseDateTimeStamp":1533709804000},{"releaseDate":"08 Aug 2018","language":"da","title":"Novo Nordisks resultat af primr drift faldt med 8% opgjort i kroner og steg med 4% i lokale valutaer i de frste seks mneder af 2018","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2209723.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2209723.html","releaseDateTimeStamp":1533709804000},{"releaseDate":"07 Aug 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2209678.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2209678.html","releaseDateTimeStamp":1533645827000},{"releaseDate":"07 Aug 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2209679.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2209679.html","releaseDateTimeStamp":1533645827000},{"releaseDate":"30 Jul 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2207900.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2207900.html","releaseDateTimeStamp":1532953273000},{"releaseDate":"30 Jul 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2207901.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2207901.html","releaseDateTimeStamp":1532953273000},{"releaseDate":"23 Jul 2018","language":"en","title":"Novo Nordisk A/S: Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2206603.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2206603.html","releaseDateTimeStamp":1532340079000},{"releaseDate":"23 Jul 2018","language":"da","title":"Novo Nordisk A/S: aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2206604.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2206604.html","releaseDateTimeStamp":1532340079000},{"releaseDate":"16 Jul 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2205402.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2205402.html","releaseDateTimeStamp":1531744549000},{"releaseDate":"16 Jul 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2205403.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2205403.html","releaseDateTimeStamp":1531744549000},{"releaseDate":"09 Jul 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2203807.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2203807.html","releaseDateTimeStamp":1531132529000},{"releaseDate":"09 Jul 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2203808.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2203808.html","releaseDateTimeStamp":1531132529000},{"releaseDate":"02 Jul 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2202534.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2202534.html","releaseDateTimeStamp":1530535926000},{"releaseDate":"02 Jul 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2202535.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2202535.html","releaseDateTimeStamp":1530535926000},{"releaseDate":"28 Jun 2018","language":"en","title":"Oral semaglutide shows superior reductions in HbA1c and weight compared to sitagliptin in the long-term safety and efficacy trial, PIONEER 3  ","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2201779.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2201779.html","releaseDateTimeStamp":1530176849000},{"releaseDate":"28 Jun 2018","language":"da","title":"Oral semaglutid viser strre reduktioner i langtidsblodsukker og vgt end sitagliptin i langtidsstudie af sikkerhed og effekt (PIONEER 3)","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2201780.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2201780.html","releaseDateTimeStamp":1530176849000},{"releaseDate":"25 Jun 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2201009.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2201009.html","releaseDateTimeStamp":1529928205000},{"releaseDate":"25 Jun 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2201010.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2201010.html","releaseDateTimeStamp":1529928205000},{"releaseDate":"20 Jun 2018","language":"en","title":"Oral semaglutide shows statistically significantly greater reductions in HbA1c and weight compared to Victoza and sitagliptin in the PIONEER 4 and 7 trials","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2200408.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2200408.html","releaseDateTimeStamp":1529526049000},{"releaseDate":"20 Jun 2018","language":"da","title":"Oral semaglutid viser statistisk signifikant strre reduktioner i langtidsblodsukker og vgt sammenlignet med Victoza og sitagliptin i PIONEER 4 og 7  ","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2200409.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2200409.html","releaseDateTimeStamp":1529526049000},{"releaseDate":"19 Jun 2018","language":"en","title":"Kallyope and Novo Nordisk announce collaboration to discover novel therapeutics for obesity and diabetes","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2199723.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2199723.html","releaseDateTimeStamp":1529406004000},{"releaseDate":"19 Jun 2018","language":"da","title":"Kallyope og Novo Nordisk indleder samarbejde om opdagelse af nye lgemidler til behandling af svr overvgt og diabetes","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2199724.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2199724.html","releaseDateTimeStamp":1529406004000},{"releaseDate":"19 Jun 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2199808.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2199808.html","releaseDateTimeStamp":1529398051000},{"releaseDate":"19 Jun 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2199809.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2199809.html","releaseDateTimeStamp":1529398051000},{"releaseDate":"11 Jun 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2198480.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2198480.html","releaseDateTimeStamp":1528716629000},{"releaseDate":"11 Jun 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2198481.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2198481.html","releaseDateTimeStamp":1528716629000},{"releaseDate":"04 Jun 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2197024.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2197024.html","releaseDateTimeStamp":1528114502000},{"releaseDate":"04 Jun 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2197025.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2197025.html","releaseDateTimeStamp":1528114502000},{"releaseDate":"29 May 2018","language":"en","title":"Oral semaglutide shows superior improvement in HbA1c vs empagliflozin in the PIONEER 2 trial","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2195846.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2195846.html","releaseDateTimeStamp":1527614561000},{"releaseDate":"29 May 2018","language":"da","title":"Oral semaglutid viser strre forbedring i langtidsblodsukker sammenlignet med empagliflozin i PIONEER 2-studiet","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2195847.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2195847.html","releaseDateTimeStamp":1527614561000},{"releaseDate":"28 May 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2195587.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2195587.html","releaseDateTimeStamp":1527508281000},{"releaseDate":"28 May 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2195588.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2195588.html","releaseDateTimeStamp":1527508281000},{"releaseDate":"22 May 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2194505.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2194505.html","releaseDateTimeStamp":1526995544000},{"releaseDate":"22 May 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2194506.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2194506.html","releaseDateTimeStamp":1526995544000},{"releaseDate":"16 May 2018","language":"en","title":"Novo Nordisk increases commitment to stem cell-based therapies","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2193101.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2193101.html","releaseDateTimeStamp":1526454071000},{"releaseDate":"16 May 2018","language":"da","title":"Novo Nordisk ger fokus p stamcellebaseret behandling","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2193102.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2193102.html","releaseDateTimeStamp":1526454071000},{"releaseDate":"14 May 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2192430.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2192430.html","releaseDateTimeStamp":1526308487000},{"releaseDate":"14 May 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram ","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2192431.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2192431.html","releaseDateTimeStamp":1526308487000},{"releaseDate":"09 May 2018","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons on 8 May 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2191519.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2191519.html","releaseDateTimeStamp":1525860577000},{"releaseDate":"09 May 2018","language":"da","title":"Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 8. maj 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2191520.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2191520.html","releaseDateTimeStamp":1525860577000},{"releaseDate":"08 May 2018","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2191209.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2191209.html","releaseDateTimeStamp":1525786137000},{"releaseDate":"08 May 2018","language":"da","title":"Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 7. maj 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2191210.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2191210.html","releaseDateTimeStamp":1525786137000},{"releaseDate":"07 May 2018","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons on 4 May 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2190836.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2190836.html","releaseDateTimeStamp":1525695313000},{"releaseDate":"07 May 2018","language":"da","title":"Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 4. maj 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2190837.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2190837.html","releaseDateTimeStamp":1525695313000},{"releaseDate":"04 May 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2190633.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2190633.html","releaseDateTimeStamp":1525466457000},{"releaseDate":"04 May 2018","language":"da","title":"Novo Nordisk A/S - Aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2190634.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2190634.html","releaseDateTimeStamp":1525466457000},{"releaseDate":"04 May 2018","language":"en","title":"Novo Nordisk A/S purchases B shares worth DKK 1,038 million from Novo Holdings A/S under the 2018 share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2190629.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2190629.html","releaseDateTimeStamp":1525463995000},{"releaseDate":"04 May 2018","language":"da","title":"Novo Nordisk A/S kber B-aktier til en vrdi af 1.038 mio. kr. fra Novo Holdings A/S som led i det samlede aktietilbagekbsprogram for 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2190630.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2190630.html","releaseDateTimeStamp":1525463995000},{"releaseDate":"03 May 2018","language":"en","title":"Trading in Novo Nordisk shares by board members, executives and associated persons on 2 May 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2190148.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2190148.html","releaseDateTimeStamp":1525357318000},{"releaseDate":"03 May 2018","language":"da","title":"Bestyrelsesmedlemmers, koncerndirektrers og nrtstende personers handel med Novo Nordisk-aktier den 2. maj 2018","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2190149.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2190149.html","releaseDateTimeStamp":1525357318000},{"releaseDate":"02 May 2018","language":"en","title":"Novo Nordisk\u0027s operating profit decreased by 8% in Danish kroner and increased by 6% in local currencies in the first three months of 2018","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2189261.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2189261.html","releaseDateTimeStamp":1525242640000},{"releaseDate":"02 May 2018","language":"da","title":"Novo Nordisks resultat af primr drift faldt med 8% opgjort i kroner og steg med 6% i lokale valutaer i de frste tre mneder af 2018","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2189262.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2189262.html","releaseDateTimeStamp":1525242640000},{"releaseDate":"01 May 2018","language":"en","title":"Novo Nordisk A/S - Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2189251.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2189251.html","releaseDateTimeStamp":1525180481000},{"releaseDate":"01 May 2018","language":"da","title":"Novo Nordisk A/S - aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2189252.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2189252.html","releaseDateTimeStamp":1525180481000},{"releaseDate":"01 May 2018","language":"en","title":" Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes   ","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2187312.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2187312.html","releaseDateTimeStamp":1525161659000},{"releaseDate":"01 May 2018","language":"da","title":"Novo Nordisk deltager i Hypo-RESOLVE - et nyt forskningsprojekt om hypoglykmi og diabetes","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2187313.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2187313.html","releaseDateTimeStamp":1525161659000},{"releaseDate":"30 Apr 2018","language":"en","title":"Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2018 ","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2189084.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2189084.html","releaseDateTimeStamp":1525109751000},{"releaseDate":"30 Apr 2018","language":"da","title":"Novo Nordisk A/S - Det samlede antal stemmerettigheder og den samlede kapital i Novo Nordisk A/S pr. 30. april 2018 ","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2189085.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2189085.html","releaseDateTimeStamp":1525109751000},{"releaseDate":"24 Apr 2018","language":"en","title":"Novo Nordisk A/S - Reduction of the share capital","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2186578.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2186578.html","releaseDateTimeStamp":1524581157000},{"releaseDate":"24 Apr 2018","language":"da","title":"Novo Nordisk A/S - Nedsttelse af aktiekapitalen","newsType":"Company Announcements","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2186579.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2186579.html","releaseDateTimeStamp":1524581157000},{"releaseDate":"23 Apr 2018","language":"en","title":"Novo Nordisk A/S: Share repurchase programme","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2186304.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2186304.html","releaseDateTimeStamp":1524495120000},{"releaseDate":"23 Apr 2018","language":"da","title":"Novo Nordisk A/S: aktietilbagekbsprogram","newsType":"Company announcements - trading in own shares","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2186305.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2186305.html","releaseDateTimeStamp":1524495120000},{"releaseDate":"18 Apr 2018","language":"en","title":" Red Cross and Novo Nordisk announce ground-breaking partnership to tackle chronic care in humanitarian crises","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"English","attachmentURL":"/bin/getPDF.2184853.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2184853.html","releaseDateTimeStamp":1524060622000},{"releaseDate":"18 Apr 2018","language":"da","title":"Rde Kors og Novo Nordisk indgr nyskabende samarbejde om behandling af kroniske sygdomme under humanitre kriser","newsType":"Press Releases","displayCheckbox":"true","isDisclaimer":"false","attachmentDetail":{"attachmentLabel":"Danish","attachmentURL":"/bin/getPDF.2184854.pdf","attachmentType":"PDF"},"newsDetailPageURL":"/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2184854.html","releaseDateTimeStamp":1524060622000}]');</script>
<script type="text/javascript" src="/etc/designs/nextweb/headlibs/dataTables.min.js"></script>
<script type="text/javascript" src="/etc/designs/nextweb/headlibs/filter.min.js"></script>
<script type="text/javascript" src="/etc/designs/nextweb/headlibs/datavalidation.min.js"></script>
<script type="text/javascript" src="/etc/designs/nextweb/headlibs/bootstrapvalidation.min.js"></script>
<!-- <script src="http://formvalidation.io/vendor/formvalidation/js/formValidation.min.js"></script>
<script src="http://formvalidation.io/vendor/formvalidation/js/framework/bootstrap.min.js"></script> -->
                <!--<hr>
                <p class="additional">If you need an older press release or company announcement that is not in the news archive, please contact: <a target="" role="" rel="" href="mailto:MediaRelations@novonordisk.com">MediaRelations@novonordisk.com</a>
                </p>-->

<script>
    var getMultidownloadPdf= '';
$('.download-selected').click(function(e){
                getMultidownloadPdf='';
                e.preventDefault();
                $('table#news-archive-table tr td input[type=checkbox]:checked').each(function( index ) {
                    getMultidownloadPdf = getMultidownloadPdf+$(this).parent().parent().find('td').eq(3).find('a').eq(0).attr('href')+',';
                });
    			//alert(getMultidownloadPdf);
                if (getMultidownloadPdf === '') {
            		return false;
                    }
                    else {
                        //alert("Submit form on year change !!");
                        $('.passgeturl').val(getMultidownloadPdf);
                        document.forms['news-archive-results-form2'].submit();
                        return true;                                            
                    }   

            });
  
</script></div>

</div>
</div>
    </div>
</div></div><footer role="footer" class="footer">
    <div class="visible-xs footer-separator">
      </div>
      <div>
      <div class="container">
        <div class="row footer-tools">
            <div class="socialnav"><div class="col-xs-12 col-sm-6 col-sm-push-6">
    <ul role="" class="social-nav">
        <li role="">
                <a href="https://twitter.com/novonordisk" rel="" role="" target="_blank">
                    <img class="img img-responsive js-image-responsive" alt="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/social-twitter-dhpx.image.50.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/social-twitter-dhpx.image.50.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/social-twitter-dhpx.image.50.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/social-twitter-dhpx.image.50.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/social-twitter-dhpx.image.50.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/social-twitter-dhpx.image.50.0.png" src="/content/dam/Denmark/HQ/Commons/images/social-twitter-dhpx.image.50.0.png"></a>
            </li>

        <li role="">
                <a href="https://www.facebook.com/novonordisk" rel="" role="" target="_blank">
                    <img class="img img-responsive js-image-responsive" alt="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/social-facebook-dhpx.image.50.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/social-facebook-dhpx.image.50.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/social-facebook-dhpx.image.50.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/social-facebook-dhpx.image.50.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/social-facebook-dhpx.image.50.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/social-facebook-dhpx.image.50.0.png" src="/content/dam/Denmark/HQ/Commons/images/social-facebook-dhpx.image.50.0.png"></a>
            </li>

        <li role="">
                <a href="https://www.youtube.com/user/novonordisk/custom" rel="" role="" target="_blank">
                    <img class="img img-responsive js-image-responsive" alt="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/social-youtube-dhpx.image.50.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/social-youtube-dhpx.image.50.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/social-youtube-dhpx.image.50.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/social-youtube-dhpx.image.50.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/social-youtube-dhpx.image.50.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/social-youtube-dhpx.image.50.0.png" src="/content/dam/Denmark/HQ/Commons/images/social-youtube-dhpx.image.50.0.png"></a>
            </li>

        <li role="">
                <a href="https://www.linkedin.com/company/novo-nordisk/careers" rel="" role="" target="_blank">
                    <img class="img img-responsive js-image-responsive" alt="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/social-linkedin-dhpx.image.50.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/social-linkedin-dhpx.image.50.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/social-linkedin-dhpx.image.50.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/social-linkedin-dhpx.image.50.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/social-linkedin-dhpx.image.50.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/social-linkedin-dhpx.image.50.0.png" src="/content/dam/Denmark/HQ/Commons/images/social-linkedin-dhpx.image.50.0.png"></a>
            </li>

        <li role="">
                <a href="https://instagram.com/novonordisk/" rel="" role="" target="_blank">
                    <img class="img img-responsive js-image-responsive" alt="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/instagram-logo-glyph.image.50.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/instagram-logo-glyph.image.50.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/instagram-logo-glyph.image.50.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/instagram-logo-glyph.image.50.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/instagram-logo-glyph.image.50.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/instagram-logo-glyph.image.50.0.png" src="/content/dam/Denmark/HQ/Commons/images/instagram-logo-glyph.image.50.0.png"></a>
            </li>

        <li role="" class="social-overview">
                <!-- START c8-icon-link component-->
                <div class="icon-link icon-medium">
                    <a href="/about-novo-nordisk/social-media-channels.html" rel="" role="" target="">
                    <img class="img img-responsive js-image-responsive" alt="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/social-overview-dhpx.image.50.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/social-overview-dhpx.image.50.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/social-overview-dhpx.image.50.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/social-overview-dhpx.image.50.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/social-overview-dhpx.image.50.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/social-overview-dhpx.image.50.0.png" src="/content/dam/Denmark/HQ/Commons/images/social-overview-dhpx.image.50.0.png"><span>Overview</span></a>
                </div>
                <!-- END c8-icon-link component-->
            </li>
       	</ul>
</div>
<div class="col-xs-12 col-sm-6 col-sm-pull-6 accessibility-link">
    </div></div>
</div>
        <div class="footer-main">
            <div class="footerpar iparsys parsys"><div class="section"><div class="new"></div>
</div><div class="iparys_inherited"><div class="footerpar iparsys parsys"><div class="multicolumn section"><div class="row ">
            <div class="col-xs-12 col-sm-3">
                    <div class="par-c0 parsys"><div class="footercontainer multicolumn section"><div class="footer-section">
    <div class="footersection_par parsys"><div class="novotext text parbase section">
    
    <h4>Who we are</h4>
 <p>Novo Nordisk is a global healthcare company with more than 95 years
  of innovation and leadership in diabetes care. This heritage has given
  us experience and capabilities that also enable us to help people
  defeat obesity, haemophilia, growth disorders and other serious
  chronic diseases.<br> <br> Headquartered in Denmark, Novo Nordisk
  employs approximately 43,200 people in 80 countries, and markets its
  products in more than 170 countries.&nbsp;</p>

    
    
</div>

</div>
</div>
</div>

</div>
</div>

            <div class="col-xs-12 col-sm-3">
                    <div class="par-c1 parsys"><div class="footercontainer multicolumn section"><div class="footer-section">
    <div class="footersection_par parsys"><div class="novonordisklinks section"><div class="">
    <div class="title novotitle"><div class="block-title">
            <h4 id="">Novo Nordisk websites</h4>
        </div>
    </div>
<div class="small-list-block">
        <ul role="" class="link-list">
            
            <li role="">
                    <!-- START c8-list-link component-->	
	                <a href="http://novonordisk-us.com" rel="" role="" target="_blank" class="list-link icon-small">                    	
	                <img class="img img-responsive js-image-responsive" alt="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/flag-us-dhpx.image.32.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/flag-us-dhpx.image.32.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/flag-us-dhpx.image.32.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/flag-us-dhpx.image.32.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/flag-us-dhpx.image.32.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/flag-us-dhpx.image.32.0.png" src="/content/dam/Denmark/HQ/Commons/images/flag-us-dhpx.image.32.0.png"><span>Novo Nordisk in the USA</span>

					</a>
                    <!-- END c8-list-link component-->
	            </li>
	            
	        <li role="">
                    <!-- START c8-list-link component-->	
	                <a href="http://www.novonordisk.dk/" rel="" role="" target="_blank" class="list-link icon-small">                    	
	                <img class="img img-responsive js-image-responsive" alt="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/flag-denmark-dhpx.image.32.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/flag-denmark-dhpx.image.32.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/flag-denmark-dhpx.image.32.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/flag-denmark-dhpx.image.32.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/flag-denmark-dhpx.image.32.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/flag-denmark-dhpx.image.32.0.png" src="/content/dam/Denmark/HQ/Commons/images/flag-denmark-dhpx.image.32.0.png"><span>Novo Nordisk in Denmark</span>

					</a>
                    <!-- END c8-list-link component-->
	            </li>
	            
	        </ul>
	</div>
</div></div>
<div class="novowebsites section"><div class="select-sites">
	<label for="" class="custom-select-label">Or choose:</label>
    <div class="custom-select-wrapper stacked onSelectChange">
            <select name="firstDropDown" style="display: none;">
                <option disabled="disabled" value="" selected="selected">Affiliate sites</option>
                <option data-attr="true" value="http://www.novonordisk.com.ar">Argentina</option>
                    <option data-attr="true" value="http://www.novonordisk.com.au">Australia</option>
                    <option data-attr="true" value="http://www.novonordisk.at/">Austria</option>
                    <option data-attr="true" value="http://www.novonordisk.be/">Belgium</option>
                    <option data-attr="true" value="http://www.novonordisk.com.br">Brazil</option>
                    <option data-attr="true" value="http://www.novonordisk.bg">Bulgaria</option>
                    <option data-attr="true" value="http://novonordisk.ca">Canada</option>
                    <option data-attr="true" value="http://www.novonordisk.cl/">Chile</option>
                    <option data-attr="true" value="http://www.novonordisk.com.cn/">China</option>
                    <option data-attr="true" value="http://www.novonordisk.com.co/">Colombia</option>
                    <option data-attr="true" value="http://www.novonordisk.hr/">Croatia</option>
                    <option data-attr="true" value="http://www.novonordisk.cz/">Czech Republic</option>
                    <option data-attr="true" value="http://www.novonordisk.dk/">Denmark</option>
                    <option data-attr="true" value="http://www.novonordisk.ee">Estonia</option>
                    <option data-attr="true" value="http://www.novonordisk.fi/">Finland</option>
                    <option data-attr="true" value="http://www.novonordisk.fr">France</option>
                    <option data-attr="true" value="http://novonordisk.de/">Germany</option>
                    <option data-attr="true" value="http://www.novonordisk.gr/">Greece</option>
                    <option data-attr="true" value="http://www.novonordisk.com.hk/">Hong Kong</option>
                    <option data-attr="true" value="http://www.novonordisk.hu/">Hungary</option>
                    <option data-attr="true" value="http://www.novonordisk.co.in/">India</option>
                    <option data-attr="true" value="http://www.novonordisk.ie/">Ireland</option>
                    <option data-attr="true" value="http://www.novonordisk.co.il/">Israel</option>
                    <option data-attr="true" value="http://www.novonordisk.it/">Italy</option>
                    <option data-attr="true" value="http://www.novonordisk.co.jp/">Japan</option>
                    <option data-attr="true" value="http://www.novonordisk.lv/">Latvia</option>
                    <option data-attr="true" value="http://www.novonordisk.lt">Lithuania</option>
                    <option data-attr="true" value="http://www.novonordisk.com.mx/">Mexico</option>
                    <option data-attr="true" value="http://www.novonordisk.md/">Moldova</option>
                    <option data-attr="true" value="http://www.novonordisk.nl/">Netherlands</option>
                    <option data-attr="true" value="http://www.novonordisk.co.nz/">New Zealand</option>
                    <option data-attr="true" value="http://www.novonordisk.no/">Norway</option>
                    <option data-attr="true" value="http://www.novonordisk.pk/">Pakistan</option>
                    <option data-attr="true" value="http://www.novonordisk.pl/">Poland</option>
                    <option data-attr="true" value="http://www.novonordisk.pt/">Portugal</option>
                    <option data-attr="true" value="http://www.novonordisk.ru">Russia</option>
                    <option data-attr="true" value="http://www.novonordisk.com.sa">Saudi Arabia</option>
                    <option data-attr="true" value="http://www.novonordisk.rs/">Serbia</option>
                    <option data-attr="true" value="http://www.novonordisk.sk/">Slovakia</option>
                    <option data-attr="true" value="http://www.novonordisk.si/">Slovenia</option>
                    <option data-attr="true" value="http://www.novonordisk.co.kr/">South Korea</option>
                    <option data-attr="true" value="http://www.novonordisk.es/">Spain</option>
                    <option data-attr="true" value="http://www.novonordisk.se/">Sweden</option>
                    <option data-attr="true" value="http://www.novonordisk.ch/">Switzerland</option>
                    <option data-attr="true" value="http://www.novonordisk.com.tw/">Taiwan</option>
                    <option data-attr="true" value="http://www.novonordisk.tn/">Tunisia</option>
                    <option data-attr="true" value="http://www.novonordisk.com.tr/">Turkey</option>
                    <option data-attr="true" value="http://www.novonordisk.ua">Ukraine</option>
                    <option data-attr="true" value="http://www.novonordisk.ae/"> United Arab Emirates</option>
                    <option data-attr="true" value="http://novonordisk.co.uk/">United Kingdom</option>
                    <option data-attr="true" value="http://www.novonordisk-us.com/">USA</option>
                    <option data-attr="" value="http://www.novonordisk.com.ve/">Venezuela</option>
                    
            </select><div class="btn-group multiple-select-btn"><button type="button" class="multiselect customSelect customSelectInner bs-customSelect dropdown-toggle" data-toggle="dropdown">Affiliate sites </button><ul class="multiselect-container dropdown-menu" style="max-height: 200px; overflow: hidden auto;"><li class="disabled"><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')" tabindex="-1"><label class="radio"><input type="radio" name="" value="" disabled=""> Affiliate sites</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.ar" value="http://www.novonordisk.com.ar"> Argentina</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.au" value="http://www.novonordisk.com.au"> Australia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.at/" value="http://www.novonordisk.at/"> Austria</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.be/" value="http://www.novonordisk.be/"> Belgium</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.br" value="http://www.novonordisk.com.br"> Brazil</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.bg" value="http://www.novonordisk.bg"> Bulgaria</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://novonordisk.ca" value="http://novonordisk.ca"> Canada</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.cl/" value="http://www.novonordisk.cl/"> Chile</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.cn/" value="http://www.novonordisk.com.cn/"> China</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.co/" value="http://www.novonordisk.com.co/"> Colombia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.hr/" value="http://www.novonordisk.hr/"> Croatia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.cz/" value="http://www.novonordisk.cz/"> Czech Republic</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.dk/" value="http://www.novonordisk.dk/"> Denmark</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.ee" value="http://www.novonordisk.ee"> Estonia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.fi/" value="http://www.novonordisk.fi/"> Finland</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.fr" value="http://www.novonordisk.fr"> France</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://novonordisk.de/" value="http://novonordisk.de/"> Germany</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.gr/" value="http://www.novonordisk.gr/"> Greece</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.hk/" value="http://www.novonordisk.com.hk/"> Hong Kong</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.hu/" value="http://www.novonordisk.hu/"> Hungary</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.co.in/" value="http://www.novonordisk.co.in/"> India</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.ie/" value="http://www.novonordisk.ie/"> Ireland</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.co.il/" value="http://www.novonordisk.co.il/"> Israel</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.it/" value="http://www.novonordisk.it/"> Italy</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.co.jp/" value="http://www.novonordisk.co.jp/"> Japan</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.lv/" value="http://www.novonordisk.lv/"> Latvia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.lt" value="http://www.novonordisk.lt"> Lithuania</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.mx/" value="http://www.novonordisk.com.mx/"> Mexico</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.md/" value="http://www.novonordisk.md/"> Moldova</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.nl/" value="http://www.novonordisk.nl/"> Netherlands</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.co.nz/" value="http://www.novonordisk.co.nz/"> New Zealand</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.no/" value="http://www.novonordisk.no/"> Norway</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.pk/" value="http://www.novonordisk.pk/"> Pakistan</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.pl/" value="http://www.novonordisk.pl/"> Poland</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.pt/" value="http://www.novonordisk.pt/"> Portugal</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.ru" value="http://www.novonordisk.ru"> Russia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.sa" value="http://www.novonordisk.com.sa"> Saudi Arabia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.rs/" value="http://www.novonordisk.rs/"> Serbia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.sk/" value="http://www.novonordisk.sk/"> Slovakia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.si/" value="http://www.novonordisk.si/"> Slovenia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.co.kr/" value="http://www.novonordisk.co.kr/"> South Korea</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.es/" value="http://www.novonordisk.es/"> Spain</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.se/" value="http://www.novonordisk.se/"> Sweden</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.ch/" value="http://www.novonordisk.ch/"> Switzerland</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.tw/" value="http://www.novonordisk.com.tw/"> Taiwan</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.tn/" value="http://www.novonordisk.tn/"> Tunisia</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.tr/" value="http://www.novonordisk.com.tr/"> Turkey</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.ua" value="http://www.novonordisk.ua"> Ukraine</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.ae/" value="http://www.novonordisk.ae/">  United Arab Emirates</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://novonordisk.co.uk/" value="http://novonordisk.co.uk/"> United Kingdom</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk-us.com/" value="http://www.novonordisk-us.com/"> USA</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk.com.ve/" value="http://www.novonordisk.com.ve/"> Venezuela</label></a></li></ul></div>
        </div>
    <div class="custom-select-wrapper stacked onSelectChange">
            <select name="firstDropDown" style="display: none;">
                <option disabled="disabled" value="" selected="selected">Other sites</option>
                <option data-attr="true" value="http://www.citieschangingdiabetes.com/  ">Cities Changing Diabetes </option>
                    <option data-attr="true" value="http://www.novonordisk-trials.com">Clinical Trials </option>
                    <option data-attr="true" value="http://novoholdings.dk">Novo Holdings A/S </option>
                    <option data-attr="true" value="http://www.novonordiskfonden.dk">Novo Nordisk Foundation</option>
                    <option data-attr="true" value="http://www.NNHF.org">Novo Nordisk Haemophilia Foundation </option>
                    <option data-attr="true" value="https://novonordiskpharmatech.com/">Novo Nordisk Pharmatech A/S</option>
                    <option data-attr="true" value="https://www.worlddiabetesfoundation.org/">World Diabetes Foundation</option>
                    
            </select><div class="btn-group multiple-select-btn"><button type="button" class="multiselect customSelect customSelectInner bs-customSelect dropdown-toggle" data-toggle="dropdown">Other sites </button><ul class="multiselect-container dropdown-menu" style="max-height: 200px; overflow: hidden auto;"><li class="disabled"><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')" tabindex="-1"><label class="radio"><input type="radio" name="" value="" disabled=""> Other sites</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.citieschangingdiabetes.com/  " value="http://www.citieschangingdiabetes.com/  "> Cities Changing Diabetes </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordisk-trials.com" value="http://www.novonordisk-trials.com"> Clinical Trials </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://novoholdings.dk" value="http://novoholdings.dk"> Novo Holdings A/S </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.novonordiskfonden.dk" value="http://www.novonordiskfonden.dk"> Novo Nordisk Foundation</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="http://www.NNHF.org" value="http://www.NNHF.org"> Novo Nordisk Haemophilia Foundation </label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="https://novonordiskpharmatech.com/" value="https://novonordiskpharmatech.com/"> Novo Nordisk Pharmatech A/S</label></a></li><li><a href="javascript:void(0);" onclick="$(this).parents('.btn-group').removeClass('open')"><label class="radio"><input type="radio" name="https://www.worlddiabetesfoundation.org/" value="https://www.worlddiabetesfoundation.org/"> World Diabetes Foundation</label></a></li></ul></div>
        </div>
    </div></div>

</div>
</div>
</div>

</div>
</div>

            <div class="col-xs-12 col-sm-3">
                    <div class="par-c2 parsys"><div class="footercontainer multicolumn section"><div class="footer-section">
    <div class="footersection_par parsys"><div class="novotext text parbase section">
    
    <h4>Novo Nordisk Worldwide</h4>

    
    
</div>
<div class="customstyles section"><div class="row">
        <div class="" style="" id="">
            <div class="customstyles_par parsys"><div class="image section"><a href="/about-novo-nordisk/worldmap.html" rel="" role="" target="">
		<img class="img img-responsive js-image-responsive rounded-border " title="" alt="Novo Nordisk Worldwide - global contact information" role="" data-hdmdsrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.380.0.png" data-hdsmsrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.380.0.png" data-mdsrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.190.0.png" data-smsrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.190.0.png" data-hdxssrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.520.0.png" data-xssrc="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.260.0.png" src="/content/dam/Denmark/HQ/Commons/images/worldmap-transparent-bg.image.260.0.png"></a>
		<script type="text/javascript" src="/etc/designs/nextweb/apps/components/image/clientlibs.min.js"></script>
</div>

</div>
</div>
    </div>
</div>
<div class="novotext text parbase section">
    
    <p>
  <a href="/about-novo-nordisk/worldmap.html" adhocenable="false">Addresses and global contacts</a></p>
 <p>&nbsp;</p>

    
    
</div>
<div class="novotext text parbase section">
    
    <h3>
  <span class="error">Important safety information about colour change
    for Fiasp<sup></sup> FlexTouch<sup></sup> and Fiasp<sup></sup> Penfill<sup></sup></span></h3>

    
    
</div>
<div class="novotext text parbase section">
    
    <p>
  <a adhocenable="false" href="/content/dam/Denmark/HQ/Commons/documents/safety-information/fiasp-safety-information.pdf" target="_blank">Read more about the issue<br> </a></p>

    
    
</div>

</div>
</div>
</div>

</div>
</div>

            <div class="col-xs-12 col-sm-3">
                    <div class="par-c3 parsys"><div class="footercontainer multicolumn section"><div class="footer-section">
    <div class="footersection_par parsys"><div class="novotext text parbase section">
    
    <h4>Shareholder Information</h4>

    
    
</div>
<div class="iframevideo section"><iframe width="100%" height="90" seamless="seamless" src="https://ir2.flife.de/data/novo_nordisk/ticker_top_er.php" webkitallowfullscreen="1" mozallowfullscreen="1" allowfullscreen="1" frameborder="0" border="0" scrolling="yes"></iframe>
                </div>
<div class="novotext text parbase section">
    
    <p>
  <a href="/investors/Shareinformation/share-monitor.html" adhocenable="false">Share Info</a></p>

    
    
</div>

</div>
</div>
</div>
<div class="footercontainer multicolumn section"><div class="footer-section">
    <div class="footersection_par parsys"><div class="novotext text parbase section">
    
    <h4>Annual reporting</h4>
 <p>
  <a adhocenable="false" href="/annual-report.html">Annual
    Report 2018</a></p>

    
    
</div>

</div>
</div>
</div>
<div class="footercontainer multicolumn section"><div class="footer-section">
    <div class="footersection_par parsys"><div class="novotext text parbase section">
    
    <h4>Contact quick links</h4>

    
    
</div>
<div class="novonordisklinks section"><div class="">
    <div class="title novotitle"></div>
<div class="small-list-block">
        <ul role="" class="link-list">
            
            <li role="">
                    <!-- START c8-list-link component-->	
	                <a href="/contact-us.html" rel="" role="" target="" class="list-link">                    	
	                <span>Contact customer services<br>in your country</span>

					</a>
                    <!-- END c8-list-link component-->
	            </li>
	            
	        <li role="">
                    <!-- START c8-list-link component-->	
	                <a href="/contact-us/report-side-effects.html" rel="" role="" target="" class="list-link">                    	
	                <span>Report a side effect</span>

					</a>
                    <!-- END c8-list-link component-->
	            </li>
	            
	        <li role="">
                    <!-- START c8-list-link component-->	
	                <a href="/contact-us/product-complaints.html" rel="" role="" target="" class="list-link">                    	
	                <span>Report product complaints</span>

					</a>
                    <!-- END c8-list-link component-->
	            </li>
	            
	        <li role="">
                    <!-- START c8-list-link component-->	
	                <a href="/contact-us/falsified-products.html" rel="" role="" target="" class="list-link">                    	
	                <span>Report falsified products</span>

					</a>
                    <!-- END c8-list-link component-->
	            </li>
	            
	        <li role="">
                    <!-- START c8-list-link component-->	
	                <a href="/contact-us/compliance-hotline.html" rel="" role="" target="" class="list-link">                    	
	                <span>Report a concern to the Compliance Hotline</span>

					</a>
                    <!-- END c8-list-link component-->
	            </li>
	            
	        <li role="">
                    <!-- START c8-list-link component-->	
	                <a href="/media/contact-media.html" rel="" role="" target="" class="list-link">                    	
	                <span>Media contact</span>

					</a>
                    <!-- END c8-list-link component-->
	            </li>
	            
	        </ul>
	</div>
</div></div>

</div>
</div>
</div>

</div>
</div>

            </div>
    </div>
<div class="ghost section">

</div>
<div class="script section"><script>
$('#contact_DK_modal').on('show.bs.modal', function (e) {
	$("#contact_DK_modal #js_multipage-contactus-form").trigger('reset');
	$('#contact_DK_modal').find("select").each(function(i, obj) {
        var dropdownBlock = $(this).closest(".form_rightcol");
        var defaultvalue =  $(this).find(">:first-child").text(); 
        dropdownBlock.find("button").text(defaultvalue);
}); 
	$(".form_captcha_refresh .form_button").trigger("click");
	$(".form_captcha_input input").attr("autocomplete","off");
	$("#contact_DK_modal #js_multipage-contactus-form").parsley().reset();
	$('#contact_DK_modal .global-error-message').addClass('hidden');
	$("#contact_DK_modal .custom-server-message-1").remove();
    $("#contact_DK_modal #contactus").show();
	$("#contact_DK_modal #contactusthankyou").hide();
});

$("#contact_DK_modal .form_button_submit").click(function(e) {
$("#contact_DK_modal .form_button_submit").removeAttr('disabled');
e.preventDefault();
$("#js_multipage-contactus-form").parsley().validate();
$('.custom-server-message-1').addClass('hidden');
var overlaySettingsForm = $("#js_multipage-contactus-form");
    var postURL = "/content/Denmark/HQ/www-novonordisk-com/en_gb/home.html";
    var dataToSend = overlaySettingsForm.serialize()+"&CaptchaValidate=true";
	
	

$.ajax( {
        url : postURL,
        type : 'POST',
        data : dataToSend,
        async : false,
        success : function(data) {
            data = $.trim(data);
            if(data=="success"){                
				$("#js_multipage-contactus-form").submit();
				$("#contact_DK_modal .form_button_submit").removeAttr('disabled');
            }else{
				$("#contact_DK_modal").find('.error-container').append('<div class="custom-server-message-1" style="font-size:14px; margin-bottom: 5px; color:#e64a0e">*Please re-enter the <b>I am human</b> code</div>');
				$("#contact_DK_modal .form_button_submit").removeAttr('disabled');
				$("#contact_DK_modal .form_captcha_refresh .form_button").trigger('click');			
            }
            return true;
        }
    });
	});
$(".contact-us-form .form_captcha_input input").keyup(function() {
					$(".custom-server-message-1").remove();
  
				});	
	
</script></div>
<div class="script section"><script type="text/javascript">
!function(b,c,f,g,h,i,j){b[h]||(b[h]=function(){(b[h].q=b[h].q||[]).push(arguments)},b[h].q=b[h].q||[],i=c.createElement(f),j=c.getElementsByTagName(f)[0],i.async=1,i.src=g,j.parentNode.insertBefore(i,j))}(window,document,"script","//dmcqaqmkk1tj3.cloudfront.net/novonordisk.js","ontame"); 
</script></div>
</div>
</div>
</div>
</div>
      </div>
      </div>

<div class="footertoolbar"><div class="footer-bottom">
    <div class="container">
        <a href="/utils/copyright.html" rel="" role="" target="_blank"> 2019 Novo Nordisk A/S</a>
        <a href="/utils/disclaimer.html" rel="" role="" target="_blank">Disclaimer/Privacy</a>
        <a href="/sitemap.html" rel="" role="" target="">Sitemap</a>
        <a href="/contact-us.html" rel="" role="" target="">Contact us</a>
        </div>
</div></div>
</footer>








<!--
More detailed timing info is available by uncommenting some code in the timing.jsp component
Timing chart URL:
http://chart.apis.google.com/chart?chtt=+%28222515ms%29&cht=bhs&chxt=x&chco=c6d9fd,4d89f9&chbh=a&chds=0,222515,0,222515&chxr=0,0,222515&chd=t:6,2829,6781,6968,7241,7850,8087,8928,9166,9728,11551,12360,12522,13204,94893,95806,100417,101058,102106,102759,103430,104594,105134,105684,106284,106650,107197,107864,109835,110176,110773,111114,111804,112124,112619,113078,115086,116931,122139,182097,182829,183720,184189,184753,185372,186075,186391,187038,187446,189345,189594,190169,190480,191224,192107,196768,197153,197871,198376,200037,200582,201266,201948,203365,204954,207050,207367,207941,208350,209701,210176,211442,212091,212484,213917,214479,214984,216309,217268,217727,218349,221419,222191|1122,5398,951,590,315,116,133,185,91236,90657,294,138,82598,81890,195,607,81659,524,122,3814,687,1969,92,869,253,75422,103,1559,71151,4589,557,187,2949,2618,2103,1626,718,4400,58819,39581,433,37910,101,36864,32164,2922,2578,1920,1493,7045,6788,6188,1374,169,4217,9729,9335,8607,1362,1577,1018,320,1161,1212,1509,10475,3946,3363,1102,241,1114,2290,1629,1218,3598,3026,1140,1185,161,305,2781,184,324&chly=handleSecurity|head.jsp|headlibs.jsp|init.jsp|browsermap.jsp|init.jsp|title.jsp|clientcontext.jsp|header.jsp|headertoolbar.jsp|logo.jsp|searchbox.jsp|navigation.jsp|meganavigation.jsp|extra-elements.jsp|drclicklogout.jsp|content.jsp|leftNavigationMobile.jsp|parsys.jsp|breadcrumbplaceholder.jsp|breadcrumbs.jsp|iparsys.jsp|new.jsp|par.jsp|socialsharebutton.jsp|column.jsp|parsys.jsp|leftNavigationDesktop.jsp|parsys.jsp|multicolumn.jsp|parsys.jsp|novotitle.jsp|parsys.jsp|customstyles.jsp|parsys.jsp|text.html|text.html|newssearch.jsp|newssearchresult.jsp|footer.jsp|socialnav.jsp|iparsys.jsp|new.jsp|par.jsp|multicolumn.jsp|parsys.jsp|footercontainer.jsp|parsys.jsp|text.html|parsys.jsp|footercontainer.jsp|parsys.jsp|novonordisklinks.jsp|novotitle.jsp|novowebsites.jsp|parsys.jsp|footercontainer.jsp|parsys.jsp|text.html|customstyles.jsp|parsys.jsp|image.jsp|text.html|text.html|text.html|parsys.jsp|footercontainer.jsp|parsys.jsp|text.html|iframevideo.jsp|text.html|footercontainer.jsp|parsys.jsp|text.html|footercontainer.jsp|parsys.jsp|text.html|novonordisklinks.jsp|novotitle.jsp|ghost.jsp|script.jsp|script.jsp|footertoolbar.jsp&chs=600x500
-->

<link rel="stylesheet" href="/etc/designs/plasticparts/footerlibs.min.css" type="text/css">
<script type="text/javascript" src="/etc/designs/plasticparts/footerlibs.min.js"></script>
<script type="text/javascript" src="/etc/designs/nextweb/headlibs/main.min.js"></script><div id="ui-datepicker-div" class="ui-datepicker ui-widget ui-widget-content ui-helper-clearfix ui-corner-all" style="position: absolute; top: 444px; left: 388.828px; z-index: 1; display: none;"><div class="ui-datepicker-header ui-widget-header ui-helper-clearfix ui-corner-all"><a class="ui-datepicker-prev ui-corner-all" data-handler="prev" data-event="click" title="Prev"><span class="ui-icon ui-icon-circle-triangle-w">Prev</span></a><a class="ui-datepicker-next ui-corner-all" data-handler="next" data-event="click" title="Next"><span class="ui-icon ui-icon-circle-triangle-e">Next</span></a><div class="ui-datepicker-title"><span class="ui-datepicker-month">April</span>&nbsp;<span class="ui-datepicker-year">2019</span></div></div><table class="ui-datepicker-calendar"><thead><tr><th scope="col" class="ui-datepicker-week-end"><span title="Sunday">Su</span></th><th scope="col"><span title="Monday">Mo</span></th><th scope="col"><span title="Tuesday">Tu</span></th><th scope="col"><span title="Wednesday">We</span></th><th scope="col"><span title="Thursday">Th</span></th><th scope="col"><span title="Friday">Fr</span></th><th scope="col" class="ui-datepicker-week-end"><span title="Saturday">Sa</span></th></tr></thead><tbody><tr><td class=" ui-datepicker-week-end ui-datepicker-other-month ui-datepicker-unselectable ui-state-disabled">&nbsp;</td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">1</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">2</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">3</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">4</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">5</a></td><td class=" ui-datepicker-week-end " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">6</a></td></tr><tr><td class=" ui-datepicker-week-end " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">7</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">8</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">9</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">10</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">11</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">12</a></td><td class=" ui-datepicker-week-end " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">13</a></td></tr><tr><td class=" ui-datepicker-week-end " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">14</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">15</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">16</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">17</a></td><td class=" ui-datepicker-days-cell-over  ui-datepicker-current-day ui-datepicker-today" data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default ui-state-highlight ui-state-active" href="#">18</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">19</a></td><td class=" ui-datepicker-week-end " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">20</a></td></tr><tr><td class=" ui-datepicker-week-end " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">21</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">22</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">23</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">24</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">25</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">26</a></td><td class=" ui-datepicker-week-end " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">27</a></td></tr><tr><td class=" ui-datepicker-week-end " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">28</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">29</a></td><td class=" " data-handler="selectDay" data-event="click" data-month="3" data-year="2019"><a class="ui-state-default" href="#">30</a></td><td class=" ui-datepicker-other-month ui-datepicker-unselectable ui-state-disabled">&nbsp;</td><td class=" ui-datepicker-other-month ui-datepicker-unselectable ui-state-disabled">&nbsp;</td><td class=" ui-datepicker-other-month ui-datepicker-unselectable ui-state-disabled">&nbsp;</td><td class=" ui-datepicker-week-end ui-datepicker-other-month ui-datepicker-unselectable ui-state-disabled">&nbsp;</td></tr></tbody></table></div>
<script type="text/javascript">
    function readCookie(name) {
        var nameEQ = name + "=";
        var ca = document.cookie.split(';');
        for (var i = 0; i < ca.length; i++) {
            var c = ca[i];
            while (c.charAt(0) == ' ') c = c.substring(1, c.length);
            if (c.indexOf(nameEQ) == 0) return (c.substring(nameEQ.length, c.length));
        }
        return null;
    }


    //code commented to remove usercookie
    function isLoggedIn() {
        var userCookie = readCookie("crx_user_key");
        if (userCookie == undefined || userCookie == null || userCookie == "") {
            return false;
        } else {
            return true;
        }
    }


    $(document).ready(function () {
        if (isLoggedIn()) {
            $(".logged-in-links").removeClass('hidden');
        } else {
            $(".logged-out-links").removeClass('hidden');
        }
    });

</script>
<div class="siteimprove"><script type="text/javascript">
        /*<![CDATA[*/
        (function() {
            var sz = document.createElement('script'); 
            sz.type = 'text/javascript'; 
            sz.async = true;
            sz.src = '//ssl.siteimprove.com/js/siteanalyze_667563.js';
            var s = document.getElementsByTagName('script')[0]; 
            s.parentNode.insertBefore(sz, s);
        })();
        /*]]>*/
    </script>
</div>
<!--script src="/etc/designs/nextweb/headlibs/js/vendor.js"></script>

<script src="/etc/designs/nextweb/headlibs/js/jquery.dataTables.min.js"></script>
<script src="/etc/designs/nextweb/headlibs/js/jquery.filter.js"></script>
<script src="/etc/designs/nextweb/headlibs/js/main.js"></script-->
<div class="cloudservices servicecomponents"><div class="cloudservice sitecatalyst"><script type="text/javascript" src="/etc.clientlibs/cq/analytics/clientlibs/sitecatalyst/sitecatalyst.min.js"></script>
<link rel="stylesheet" href="/etc.clientlibs/cq/analytics/clientlibs/sitecatalyst/tracking.min.css" type="text/css">
<script type="text/javascript" src="/etc.clientlibs/cq/personalization/clientlib/personalization/integrations/commons.min.js"></script>
<script type="text/javascript" src="/etc.clientlibs/cq/analytics/clientlibs/sitecatalyst/tracking.min.js"></script>
<script type="text/javascript" src="/etc.clientlibs/cq/analytics/clientlibs/sitecatalyst/util.min.js"></script>
<script type="text/javascript" src="/media/_jcr_content/analytics.sitecatalyst.js"></script>
<script type="text/javascript" src="/etc.clientlibs/cq/analytics/clientlibs/sitecatalyst/plugins.min.js"></script>
<script type="text/javascript" src="/media/_jcr_content/analytics.config.js"></script><span data-tracking="{event:'pageView', values:{}, componentPath:'foundation/components/page'}"></span><script type="text/javascript">
CQ_Analytics.Sitecatalyst.frameworkComponents = [''];
/**
 * Sets SiteCatalyst variables accordingly to mapped components. If <code>options</code>
 * object is provided only variables matching the options.componentPath are set.
 *
 * @param {Object} options Parameter object from CQ_Analytics.record() call. Optional.
 */
CQ_Analytics.Sitecatalyst.updateEvars = function(options) {
    this.frameworkMappings = [];
    for (var i=0; i<this.frameworkMappings.length; i++){
        var m = this.frameworkMappings[i];
        if (!options || options.compatibility || (options.componentPath == m.resourceType)) {
            CQ_Analytics.Sitecatalyst.setEvar(m);
        }
    }
}

CQ_Analytics.Sitecatalyst.doPageTrack = function() {
    var collect = true;
    var lte = s.linkTrackEvents;
    var afterCollectEvent = document.createEvent("Event");
    s.pageName="content:Denmark:HQ:www\u002Dnovonordisk\u002Dcom:en_gb:home:media:novo\u002Dnordisk\u002Dnews";
    s.contextData['AEM.pagename'] = s.pageName;
    s.contextData['AEM.site'] = "n\/a";
    

    CQ_Analytics.Sitecatalyst.collect(collect);
    if (collect) {
        CQ_Analytics.Sitecatalyst.updateEvars();
        /************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
        var s_code=s.t();if(s_code)document.write(s_code);
        s.linkTrackEvents = lte;
        if (s.linkTrackVars.indexOf('events')==-1){ delete s.events };
        afterCollectEvent.initEvent("sitecatalystAfterCollect", true, true);
        document.dispatchEvent(afterCollectEvent);
    }
};
CQ_Analytics.DataProvider.setType(ClientContext);
CQ_Analytics.DataProvider.onReady(function() {
    CQ_Analytics.Sitecatalyst.doPageTrack();
});
</script>
<noscript><img src="https://novonordiskas.112.2o7.net/b/ss/novo220685,novonordiskcp7/1/H.27.5--NS/1555566747566?cdp=2&amp;gn=content%3ADenmark%3AHQ%3Awww-novonordisk-com%3Aen_gb%3Ahome%3Amedia%3Anovo-nordisk-news" height="1" width="1" border="0" alt=""/></noscript>
</div>

</div><div id="fb-root" class=" fb_reset"><div style="position: absolute; top: -10000px; width: 0px; height: 0px;"><div><iframe name="fb_xdm_frame_https" frameborder="0" allowtransparency="true" allowfullscreen="true" scrolling="no" allow="encrypted-media" id="fb_xdm_frame_https" aria-hidden="true" title="Facebook Cross Domain Communication Frame" tabindex="-1" src="https://staticxx.facebook.com/connect/xd_arbiter/r/d_vbiawPdxB.js?version=44#channel=f38c35359e4bd8c&amp;origin=https%3A%2F%2Fwww.novonordisk.com" style="border: none;"></iframe></div><div></div></div></div>
<!-- adding script tag for Implementation of Tag Manager -->
<script>_satellite.pageBottom();</script><!-- BOWEN CRAGGS SURVEY WIDGET -->
<script src="https://app.bowencraggs.com/scripts/be087278-12d0-44f7-a939-84d6ff13b1b3.js"></script>
<!-- END OF BOWEN CRAGGS SURVEY WIDGET -->


<iframe scrolling="no" frameborder="0" allowtransparency="true" src="https://platform.twitter.com/widgets/widget_iframe.2e9f365dae390394eb8d923cba8c5b11.html?origin=https%3A%2F%2Fwww.novonordisk.com&amp;settingsEndpoint=https%3A%2F%2Fsyndication.twitter.com%2Fsettings" title="Twitter settings iframe" style="display: none;"></iframe><script src="https://px.ads.linkedin.com/collect/?time=1555566753347&amp;pid=112683&amp;url=https%3A%2F%2Fwww.novonordisk.com%2Fcontent%2FDenmark%2FHQ%2Fwww-novonordisk-com%2Fen_gb%2Fhome%2Fmedia%2Fnovo-nordisk-news.html%2F&amp;fmt=js&amp;s=1" type="text/javascript"></script><iframe src="https://bid.g.doubleclick.net/xbbe/pixel?d=KAE" style="display: none;"></iframe></body></html>